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General Introduction 
 
Yeasts are one of the fundamental organisms for fermentation, research use and 
biotechnology. The purpose of this study is to provide basic technology and information 
to make most use of yeast for biomass-based production. The outline of this research is 
depicted in Figure 1. Knowing optimum expression level of each genes is important for 
both understanding and engineering of the organisms. In chapter 1, characterization of 
promoters, which dictate downstream gene expression is performed in various media 
conditions simulating biomass utilization. Providing selection of yeast species with 
distinct characteristics such as fast growth and thermotolerance may further be 
beneficial for industrial application. In chapter 2, comprehensive and highly efficient 
genome engineering tool is developed in unconventional thermotolerant yeast. Finally, 
by utilizing the genetic engineering tools and the promoter selection, valuable protein 
production in the unconventional yeast was performed in chapter 3. 
 
Figure 1 Outline of the research. 
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1.1 Yeast Saccharomyces cerevisiae 
The budding yeast Saccharomyces cerevisiae has approximately 6000 genes 
(Lushchak 2006) and serves as eukaryotic model as it shares common cellular functions 
with higher organisms (Botstein et al. 1997; Schneiter 2007). Usefulness of S. cerevisiae 
is established with efficient genetic transformation tools including homologous 
recombination and host vector systems (Ishii et al. 2014; Gietz et al. 1992).  
Therefore, S. cerevisiae is widely used as a model organism for both basic research and 
industrial bioproduction ranging from ethanol (Katahira et al. 2006; Kondo et al. 2013; 
Hasunuma et al. 2015) to proteins (Buckholz and Gleeson 1991; (Çelik and Çalık 2012). 
 Practically, biomass is the major source for bioproduction and needs pretreatment 
to extract cellulosic and hemicellulosic materials, which are then digested by enzymes 
to become simple sugars such as glucose and xylose (Hasunuma et al. 2015). As 
conventional S. cerevisiae does not assimilate xylose, genes (XYL1 and XYL2) 
respectively encoding xylose reductase (XR) and xylitol dehydrogenase (XDH) from 
Scheffersomyces stipites have been introduced to engineer the yeast to assimilate xylose 
for the highest production from biomass (Eliasson et al. 2000; Johansson et al. 2001). 
However, the engineered strains grow on xylose much slower than on glucose 
(Salusjärvi et al. 2008; Matsushika et al. 2014), limiting its practical use. To enhance 
growth and production by genetic engineering, it is necessary to optimize gene 
expression network and fine-tune metabolic pathway, for which fundamental study is 
needed to characterize promoter activity in xylose medium. Detail of the promoter 
activity is further explained in Section1.3. 
 
1.2 Yeast Kluyveromyces marxianus 
Kluyveromyces marxianus is classified as “Crabtree negative” yeast, meaning that 
it does not convert sugars into ethanol under aerobic condition. K. marxianus is also a 
thermotolerant yeast and can grow fast at 37-42°C (Goshima et al. 2013) Recently, the 
complete genome sequence of K. marxianus becomes publicly available (Jeong et al. 
2012; Suzuki et al. 2014; Inokuma et al. 2015). Therefore, K. marxianus is potentially 
suitable for engineering to produce valuable products such as recombinant proteins. 
However, K. marxianus still lacks efficient genome engineering tools. Unlike S. 
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cerevisiae, transformation by homologous recombination (HR) is much less likely to 
occur and gene fragments tend to be inserted at random chromosomal sites (Nonklang et 
al. 2008). Supposedly, K. marxianus retains highly active non-homologous end joining 
(NHEJ) pathway (Dudášová et al. 2004), which repair DNA double-strand breaks 
(DSBs) by tethering DNA ends regardless of the sequences (Figure 2). The pathway 
facilitates random integration of DNA fragments and thus antagonizes with HR. 
Plasmid system is also useful for heterologous gene expression. For a plasmid to 
be retained in a cell, autonomously replicating sequence (ARS) and centromere are 
indispensable. ARS initiates replication of plasmid (Newlon and Theis 1993) and 
centromere is required for transmission to daughter cells (Carbon 1984). Nonetheless, 
plasmid system is less stable than genomic integration in general. Selection marker such 
as drug resistance gene is also needed to select and retain plasmid-carrying cells. 
In this study, comprehensive genome engineering tools are provided by introducing 
genome editing technology. The genome editing is described in Section 1.4. 
 
Figure 2 Mechanisms of DNA double-strand break repair by NHEJ pathway 
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1.3 Promoter activity and gene expression 
Each gene expression level is dependent on its promoter activity, which is 
responsive to the cellular environment. In yeast, PTDH3 (promoter of TDH3) is assumed 
to be highly active in glucose media (Ishii et al. 2014). PPDC1, PTEF1, PTPI1, and PPGK1 are 
also widely used for engineered gene expression (Sun et al. 2012; Ishii et al. 2014; Guo 
et al. 2016). However, promoter activity should be dependent on the environment such 
as carbon source and aeration, which can be changing throughout the culture. To 
achieve optimal set of gene expression, it is important to know the actual promoter 
activity under varying conditions. In chapter 1, activity of a set of promoters is 
quantitatively characterized in glucose or xylose medium under aerobic cultivation or 
microaerobic fermentation over time.  
 
1.4 Genome editing tools 
 
Figure 3 The principle of genome editing by CRISPR-Cas9 and Target-AID 
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・CRISPR-Cas9 system 
In bacteria and archaea, clustered regularly interspaced short palindromic repeats 
(CRISPR)/CRISPR-associated protein 9 (CRISPR-Cas9) was discovered as an acquired 
immune system against viruses and phages through CRISPR RNA (crRNA)-base DNA 
recognition and Cas9 nuclease-mediated DNA cleavage (Gasiunas et al. 2012). 
CRISPR-Cas9-mediated genome editing depends on the generation of double-strand 
break (DSB) and subsequent cellular DNA repair process (Zhang et al. 2014). The 
CRISPR-Cas9 system is depicted in Figure 3. Target-recognizing sequence of crRNA or 
guide RNA (gRNA) in general can be customized to a specific sequence, which enables 
genome editing. When introduced in a cell, Cas9 and the custom gRNA binds to 
complementary target DNA strand in a protospacer-adjacent motif (PAM)-dependent 
manner, which appears as the sequence of 5’-NGG-3’ directly downstream of the target 
sequence (Jinek et al. 2012). Cas9 nuclease induces DSB at the target site, which is then 
repaired by NHEJ pathway in the host cell. Error-prone nature of the NHEJ pathway 
may induce insertion or deletion (indel) of base pairs, resulting in gene disruption at the 
target locus. 
 
・Target-AID system 
Unlike nuclease-mediated genome editing, deaminase-mediated targeted 
mutagenesis (Target-AID) directly introduce point mutations (Nishida et al. 2016).The 
activation-induced cytidine deaminase (AID) is tethered to nuclease-deficient 
CRISPR-Cas9 to specifically induce cytosine (C) to thymine (T) mutation at -16 to -19 
positions upstream of the PAM sequence.  
 
In chapter 2, we introduced the genome editing tools CRISPR-Cas9 and 
Target-AID in K. marxianus, which enabled indel formation, highly efficient 
homologous recombination and direct introduction of point mutation at the target loci.  
 
1.5 Production of biopharmaceutical protein 
Biopharmaceutical products are promising targets for industrial production. There 
has been an increasing demand of biopharmaceutical proteins in the market (Nielsen 
2013). Efficient production and safety issues such as endotoxin and virus contamination 
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are the major challenges for biopharmaceuticals. Yeasts are one of the preferred host 
cell for production of biopharmaceutical proteins (Huang et al. 2014). As a unicellular 
microbial organism, it is easy to culture, genetically tractable, grows fast, and adjusts 
well to industrial processing. Efficient secretion system of the yeasts also reduces the 
costs of downstream purification (Huang et al. 2014). S. cerevisiae and Pichia pastoris 
are the major species on which much efforts have been done to engineer for protein 
production (Miller et al. 2005; Tang et al. 2016). In chapter 3, we engineered the K. 
marxianus as a host for producing single-chain Fv antibody (scFv). Genetic and 
physiological manipulation has been applied to probe important factors for efficient 
production. 
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Chapter 1 
Selection of yeast Saccharomyces cerevisiae promoters available for xylose 
cultivation and fermentation 
 
Introduction 
The budding yeast Saccharomyces cerevisiae has traditionally been used for 
making alcohol in the brewing industry (Lodolo et al. 2008). Because the yeast is able 
to predominantly produce ethanol, it has also been used for making biofuels over the 
last two decades (Hahn-Hägerdal et al. 2006), and recently it has been adopted as a 
platform for producing higher alcohols and other chemicals (Steen et al. 2008; Kondo et 
al. 2012; Kondo et al. 2013). Cellulosic and hemicellulosic materials, containing 
glucose and xylose as the major sugar components, are regarded as sustainable biomass 
resources, and various efforts have been made to produce bioethanol and other 
compounds from these materials using yeasts and other microbes (Hasunuma et al. 2013, 
2015).  
S. cerevisiae grows favorably on glucose, but is naturally unable to grow well on 
xylose. Engineered yeasts that express heterogenous XYL1 and XYL2 genes encoding 
xylose reductase (XR) and xylitol dehydrogenase (XDH) from Scheffersomyces stipitis, 
and the endogenous XKS1 gene encoding xylulokinase (XK) (Eliasson et al. 2000; 
Johansson et al. 2001), can utilize xylose as a carbon source. XR reduces xylose to 
xylitol by an NADPH-consuming reaction, while XDH oxidizes xylitol to xylulose by 
an NAD
+
-consuming reaction (Fernandes and Murray 2010). Then, XK phosphorylates 
xylulose into xylulose-5-phosphate (X5P), which is further metabolized via the pentose 
phosphate pathway (PPP) and joins glycolysis (Jin et al. 2003).  
Even in xylose-utilizing yeast strains expressing XR, XDH, and XK, the 
consumption rate of xylose is much slower than that of glucose (Salusjärvi et al. 2008; 
Matsushika et al. 2014). To improve xylose utilization, further engineering of other 
metabolic pathways, such as the PPP, is required (Johansson and Hahn-Hägerdal 2002). 
In addition, the ability for biomass degradation and inhibitor tolerance should be 
conferred to obtain more sophisticated hemicellulose-utilizing yeast strains. For 
example, xylanase and xylosidase have been secreted outside of cells or displayed on 
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cell surfaces as hemicellulose degradation enzymes (La Grange et al. 2001; Guirimand 
et al. 2016). And formate dehydrogenase (FDH) and Haa1 transcription factor have been 
overexpressed as a detoxification enzyme and a global transcription activator, 
respectively (Hasunuma et al. 2011b; Sakihama et al. 2015). Thus, there exist varieties 
of gene targets to be expressed in xylose-utilizing yeast strains, and it is important to 
properly control their expression levels.  
To date, many researchers have investigated the activities of S. cerevisiae 
promoters in the presence of glucose as a sole carbon source (Shen et al. 2012; Partow 
et al. 2010; Sun et al. 2012). However, there are few reports evaluating promoter 
activities using xylose as a carbon source. In one example, the activities of 6 promoters 
were measured in xylose fermentation conditions (Lu and Jeffries 2007). In addition, the 
shuffling of the promoter activities for gene expression, such as in the PPP, to optimize 
xylose utilization has been reported (Lu and Jeffries 2007; Latimer et al. 2014). 
In the present study, we aimed to expand the options of promoter choice in S. 
cerevisiae for xylose cultivation and fermentation. To choose promoter candidates, 
comprehensive gene expressions of xylose-utilizing yeast strains were analyzed both in 
xylose- and glucose-fermenting conditions using DNA microarrays. Based on 
normalized signals during xylose fermentation, we picked 30 promoter candidates that 
showed strong, moderate, and weak expressions. Using the lacZ reporter gene, the 
activities of these 30 promoters in the xylose-utilizing strain were measured over time. 
During aerobic cultivation and microaerobic fermentation, xylose and glucose were 
used as respective sole carbon sources. 
 
 
Materials and Methods 
Media and growth conditions 
The S. cerevisiae strains used in this study are listed in Table 1. Escherichia coli 
strain DH5α (Toyobo, Osaka, Japan) used for cloning was grown in Luria-Bertani 
medium (10 g/L peptone, 5 g/L yeast extract, and 5 g/L sodium chloride) supplemented 
with 100 mg/L ampicillin at 37°C. Yeast cells were grown in YPD medium (10 g/L 
yeast extract, 20 g/L peptone, and 20 g/L glucose) at 30°C. Yeast strains harboring 
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episomal plasmids were grown in SD (6.7 g/L yeast nitrogen base without amino acid 
[YNB] and 20 g/L glucose), SX (6.7 g/L YNB and 15 g/L xylose), SDX (6.7 g/L YNB, 
14 g/L glucose and 6 g/L xylose), or SDX2 (6.7 g/L YNB, 35 g/L glucose and 15 g/L 
xylose) selective medium, which contained 20 mg/L histidine and 20 mg/L methionine. 
 
Construction of plasmids and yeast transformation 
The plasmids used in this study are listed in Table 1. The open reading frame 
(ORF) of lacZ was amplified from the genomic DNA of E. coli K-12 (strain MG1655) 
as a template by PCR using the primers lacZ_Fw and lacZ_Rv. The SAG1 terminator 
(TSAG1) was amplified from the genomic DNA of S. cerevisiae BY4741 (Brachmann et 
al. 1998) as a template using the primers SAG1t_Fw and SAG1t_Rv. Two fragments of 
lacZ and TSAG1 were connected by overlap extension-PCR using the primers 
lacZ_SAG1t_Fw and lacZ_SAG1t_Rv to yield lacZ-TSAG1 fragment. The episomal 
plasmid pRS415 (Sikorski and Hieter 1989) was digested with NotI. The lacZ-TSAG1 
fragment was inserted into NotI-digested pRS415 by In-fusion cloning (Takara Bio, 
Shiga, Japan) to yield pRS415/lacZ-TSAG1.  
Promoters used in this study are listed in Table 2. The promoter fragments were 
amplified from the genomic DNA of S. cerevisiae BY4741 by PCR using the primers 
listed in Table 3. Promoter fragments were inserted into the HindIII/BamHI or 
HindIII/SalI sites of pRS415/lacZ-TSAG1 by ligation or In-fusion cloning to yield 
plasmids pRS415/Pxxxx-lacZ-TSAG1 (xxxx indicates the gene names used as candidate 
promoters). 
A fragment containing S. stipitis XR and XDH genes, the S. cerevisiae endogenous 
XK gene, and URA3 selectable marker were amplified from plasmid pIUX1X2XKN 
(Ismail et al. 2013) by PCR using the primers X-I2_Fw and X-I2_Rv. The amplified 
fragment was integrated into the I2 genomic locus (Inokuma et al. 2015) of S. cerevisiae 
strain BY4741 with the lithium acetate method (Gietz et al. 1992). The yielded 
BY4741/X-I2 strain was selected on SD selective medium additionally containing 60 
mg/L leucine. The episomal plasmids pRS415/lacZ-TSAG1 and pRS415/Pxxxx-lacZ-TSAG1 
were introduced into BY4741/X-I2 with the lithium acetate method. The yielded strains 
BY4741/X-I2-C and BY4741/X-I2-Pxxxx were selected on SD selective medium.  
14 
 
Ethanol fermentations in YP xylose- and glucose-rich media 
The strain BY4741/X-I2 was aerobically cultivated in YPD medium for 48 h at 
30°C. The cells were collected by centrifugation at 3,000 rpm for 10 min at 4°C and 
washed twice with distilled water. Then cells were inoculated into 50 mL of 
fermentation medium (10 g/L yeast extract, 20 g/L peptone) containing 50 g/L xylose or 
glucose. Fermentation was performed at 30°C with agitation at 500 rpm in 100 mL 
closed bottles equipped with a bubbling CO2 outlet under oxygen limited conditions 
(microaerobic conditions).  
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Table 1 Plasmids and S. cerevisiae strains used in this study 
 
 
Plasmids and Strains Genotype Reference 
Plasmids 
  
pIUX1X2XKN 
Genomic integration plasmid with the XR-XDH-XK expression 
cassette (PTDH3-XYL1, PCDC19-XYL2 and PTPI1-XKS1) and URA3 marker 
(Ismail et al. 2013)  
pRS415 Single-copy vector (CEN/ARS origin), LEU2 marker ATCC (Sikorski and Hieter 1989) 
pRS415/lacZ-TSAG1 lacZ and TSAG1 in pRS415 This study 
pRS415/Pxxxx-lacZ-TSAG1 Candidate promoters in pRS415/lacZ-TSAG1 This study 
   
Strains 
  
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ATCC (Brachmann et al. 1998) 
BY4741/X-I2 
BY4741 integrating pIUX1X2XKN (PTDH3-XYL1, PCDC19-XYL2 and 
PTPI1-XKS1)  
This study 
BY4741/X-I2-C BY4741/X-I2 harboring pRS415/lacZ-TSAG1 This study 
BY4741/X-I2-Pxxxx BY4741/X-I2 harboring pRS415/Pxxxx-lacZ-TSAG1 This study 
16 
 
Table 2 List of promoters used in this study 
Gene Description 
Length of the 
cloned 
upstream 
region (bp) 
ADH1 Alcohol dehydrogenase 700 
ADH3 Mitochondrial alcohol dehydrogenase isozyme III 1021 
ALD3 Cytoplasmic aldehyde dehydrogenase 574 
ALD4 Mitochondrial aldehyde dehydrogenase 1000 
CDC19 Pyruvate kinase 998 
FBA1 Fructose 1,6-bisphosphate aldolase 551 
GND1 6-phosphogluconate dehydrogenase (decarboxylating); 1000 
GND2 6-phosphogluconate dehydrogenase (decarboxylating) 999 
HXT2 
High-affinity glucose transporter of the major facilitator 
superfamily 
1000 
HXT7 High-affinity glucose transporter 587 
HXT8 Protein of unknown function with similarity to hexose transporters 1000 
LAT1 Dihydrolipoamide acetyltransferase component (E2) of the PDC 1000 
LPD1 Dihydrolipoamide dehydrogenase 673 
NQM1 Transaldolase of unknown function 1000 
PDA1 E1 alpha subunit of the pyruvate dehydrogenase (PDH) complex 190 
PDC1 Major of three pyruvate decarboxylase isozymes 793 
PDC6 Minor isoform of pyruvate decarboxylase 1002 
PGK1 3-phosphoglycerate kinase 538 
RKI1 Ribose-5-phosphate ketol-isomerase 1000 
SED1a Major stress-induced structural GPI-cell wall glycoprotein 1063 
SED1b Major stress-induced structural GPI-cell wall glycoprotein 800 
SOL4 6-phosphogluconolactonase 997 
STB5 Transcription factor 1000 
TDH1 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), isozyme 1 1000 
TDH3 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), isozyme 3 680 
TEF1 Translational elongation factor EF-1 alpha 421 
TEF2 Translational elongation factor EF-1 alpha 402 
TKL2 Transketolase 1000 
TPI1 Triose phosphate isomerase, abundant glycolytic enzyme 584 
ZWF1 Glucose-6-phosphate dehydrogenase (G6PD) 1000 
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Table 3 Primers used in this study 
Primer name Sequence (5'-3') 
lacZ_Fw ATGACCATGATTACGGATTCACTGG 
lacZ_Rv GTACTAACTGTACAGTACCCGTTCTTATTTTTGACACCAGACCAACTGG 
SAG1t_Fw CCAGTTGGTCTGGTGTCAAAAATAAAACGGGTACTGTACAGTTAGTAC 
SAG1t_Rv TTTGATTATGTTCTTTCTATTTG  
lacZ_SAG1t_Fw AGTTCTAGAGCGGCCGCATGACCATGATTACG 
lacZ_SAG1t_Rv ACCGCGGTGGCGGCCGCTTTGATTATGTTCTTTC 
pADH1_Fw AAAAAAAAGCTTGGGTGTACAATATGGACTTCCTC 
pADH1_Rv AAAAAAGGATCCGTATATGAGATAGTTGATTGTATGC 
pTDH3_Fw AAAAAAAAGCTTCAGTTCGAGTTTATCATTATC 
pTDH3_Rv AAAAAAGGATCCTTTGTTTGTTTATGTGTGTTTATTCG 
pPGK1_Fw AAAAAAAAGCTTGCCTCTTATCGAGAAAGAAATTACC 
pPGK1_Rv AAAAAAGGATCCGTTTTATATTTGTTGTAAAAAGTAG 
pHXT7_Fw AAAAAAAAGCTTCCGTGGAAATGAGGGGTATGCAGG 
pHXT7_Rv AAAAAAGGATCCTTTTTGATTAAAATTAAAAAAAC 
pTEF1_Fw AAAAAAAAGCTTCCACACACCATAGCTTCAAAATG 
pTEF1_Rv AAAAAAGGATCCTTTGTAATTAAAACTTAGATTAGATTGC 
pTEF2_Fw AAAAAAAAGCTTATTACCCATAAGGTTGTTTGTGACG 
pTEF2_Rv AAAAAAGGATCCGTTTAGTTAATTATAGTTCGTTGACCG 
pSED1(1063)_Fw AAAAAAGTCGACgaaaaacgacaacattccacc 
pSED1(1063)_Rv AAAAAAGGATCCtcttaatagagcgaacgtattttattttgc 
pTDH1_Fw AAAAAAAAGCTTCTTCCCTTTTACAGTGCTTCGG 
pTDH1_Rv AAAAAAGGATCCTTTGTTTTGTGTGTAAATTTAG 
pFBA1_Fw AAAAAAAAGCTTTGACAGCAGGATTATCGTAATACG 
pFBA1_Rv AAAAAAGGATCCTTTGAATATGTATTACTTGGTTATG 
pTPI1_Fw AAAAAAAAGCTTGTGTTTAAAGATTACGGATATTTAAC 
pTPI1_Rv AAAAAAGGATCCTTTTAGTTTATGTATGTGTTTTTTG 
pPDC1_Fw AAAAAAAAGCTTCTGGGTGAGCATATGTTCCGCTG 
pPDC1_Rv AAAAAAGGATCCTTTGATTGATTTGACTGTGTTATTTTG 
pADH3_Fw AAAAAAAAGCTTCCACGGCATTGAATCTATTTCTCC 
pADH3_Rv AAAAAAGGATCCTGATGGTGTTAACTTATGACTATAC 
pPDA1_Fw AAAAAAAAGCTTCTTCTGATTCCTCCACCCCTTCC 
pPDA1_Rv AAAAAAGGATCCTGGCACAAATGTGGTTTCCTTTC 
pLPD1_Fw AAAAAAAAGCTTAATATCGTAGCCTCGCAAAATTCC 
pLPD1_Rv AAAAAAGGATCCTGTGAACTGTTAGTATGTTCTTTG 
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pLAT1_Fw CGGTATCGATAAGCTTCTACGAGTTTGACGACTCT 
pLAT1_Rv TAGAACTAGTGGATCCAGTACGCTAATAACTATTAATTT 
pALD3_Fw AAAAAAAAGCTTAAGCACCATTATTTCAGCATGCGG 
pALD3_Rv AAAAAAGGATCCTTTTCTTTTGGCTAATTTTCTAAATG 
pCDC19_Fw AAAAAAAAGCTTAATGCTAGTATTTTGGAGATTAATC 
pCDC19_Rv AAAAAAGGATCCTGTGATGATGTTTTATTTGTTTTG 
pHXT2_Fw AAAAAAAAGCTTTTTCTACCGATGTAATACAAAAATGAATC 
pHXT2_Rv AAAAAAGGATCCTATGTTGCTTTATAAGTCTTTTTG 
pHXT8_Fw AAAAAAGTCGACTAACCCATATCTTCTTGAGGAGAGTC 
pHXT8_Rv AAAAAAGGATCCGGTTTTTGCTGGCGTTCTGAGCTAAC 
pSOL4_Fw AAAAAAAAGCTTATAGCATTATGGTATTGTCCACCAC 
pSOL4_Rv AAAAAAGGATCCTTTTCTTGAGGTGGTTGTGGATTATTTG 
pGND1_Fw AAAAAAAAGCTTGCTATGTCACTAATGATCTCGTCGG 
pGND1_Rv AAAAAAGGATCCTTTATTGTAGTTTTTGTATAGAAAGTGGC 
pRKI1_Fw AAAAAAAAGCTTGTTTGGGTGTGATAAGGTTCATTGTG 
pRKI1_Rv AAAAAAGGATCCTTCTTTCCTATGTTGTATTTATATG 
pALD4_Fw CGGTATCGATAAGCTTAGCGCTTTCCATCAAAAATAC 
pALD4_Rv TAGAACTAGTGGATCCGCTTTATTTATTTTTGTTATTGTA  
pNQM1_Fw CGGTATCGATAAGCTTGCCCTGGTTCCACAAACC  
pNQM1_Rv TAGAACTAGTGGATCCATTTAATTTCTTGTATATATGTGA 
pPDC6_Fw CGGTATCGATAAGCTTCTACCCTATTTTCTCTTACC  
pPDC6_Rv TAGAACTAGTGGATCCTTTGTTGGCAATATGTTTTTGC  
pTKL2_Fw CGGTATCGATAAGCTTTATAGTTAACTACCGGCTCG 
pTKL2_Rv TAGAACTAGTGGATCCTTTTTTGTTCTTTTTTTGATTAGT 
pGND2_Fw CGGTATCGATAAGCTTCCGTCATAACTTTGAATCCT 
pGND2_Rv TAGAACTAGTGGATCCTCTGTTCCTCGTGTTTTTTTA 
pSTB5_Fw CGGTATCGATAAGCTTGGCAAAACAATCGAGAACC 
pSTB5_Rv TAGAACTAGTGGATCCGTCCTTCTTTTACACCTTTG  
pSED1(800)_Fw CGGTATCGATAAGCTTATTGGATATAGAAAATTAACGTA 
pSED1(800)_Rv TAGAACTAGTGGATCCCTTAATAGAGCGAACGTATTT 
pZWF1_Fw CGGTATCGATAAGCTTCGCCAGCGAGCTTTCCGG 
pZWF1_Rv TAGAACTAGTGGATCCCTTGCCTTATGTGGTTTTCT 
X-I2_Fw 
agatctggatctgaatggcatcattttgtgatgtgtaaaagcgggaccttgagagtgcaccataccacagcttttcaat
t 
X-I2_Rv 
cacagcgggaaactccttagtgttcataaagaaatacgatcatatgtagtaaccgcctctccccgcgcgttggccga
ttc 
19 
 
Determination of yeast cells, ethanol, glucose, glycerol, xylose, and xylitol 
Cell growth was measured by a microplate reader at OD600. Ethanol, glucose, 
glycerol, xylose, and xylitol in medium were determined by a Shimadzu HPLC system 
equipped with a Shim-pack SPR-Pb column (7.8 mm × 250 mm; Shimadzu, Kyoto, 
Japan) and an RID-10A refractive index detector (Shimadzu) after the separation of 
cells by centrifugation at 14,000 × g for 5 min. The column temperature was 80°C. 
Water was used at a flow rate of 0.6 mL/min as the mobile phase (Hasunuma et al. 
2011a) 
 
Microarray analyses of yeast cells in xylose and glucose fermentations 
Total RNA was isolated from yeast cells cultivated for 9 h in fermentation medium 
containing 50g /L xylose or for 3 h in fermentation medium containing 50 g/L glucose 
using a Total RNA Isolation Mini Kit (Agilent Technologies, Palo Alto, CA, USA) 
following the manufacturer’s protocol. cDNA was generated by reverse transcription, 
labelled with Cy3 using a Low Input Quick Amp Labeling Kit (Agilent Technologies), 
and hybridized to S. cerevisiae 4×44k microarrays. Array scans and data analyses were 
performed with an Agilent Single-Color DNA Microarray Scanner and Genespring GX 
software, respectively (Agilent Technologies). Normalized signals were calculated by 
the 75th percentile normalization procedure.  
 
Glucose, xylose, or glucose/xylose cultivations under aerobic conditions 
BY4741/X-I2-Pxxxx strains were grown aerobically in SD selective medium 
overnight at 30°C by shaking in 96-deep-well plates with breathable sealing film 
(BMBio, Tokyo, Japan). The cells were inoculated into SD or SDX selective medium 
(OD600 ≤ 0.12), or were concentrated by centrifugation at 1,500 × g for 5 min and then 
inoculated into SX selective medium (OD600 = 0.1~0.2) in 96-deep-well plates with 
breathable sealing film. Cells were grown at 30°C by shaking at 1,200 rpm.  
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Glucose, xylose, or glucose/xylose fermentations under microaerobic conditions 
BY4741/X-I2-Pxxxx were grown aerobically in 5-times concentrated SD selective 
medium supplemented with 2-times concentrated (40 mg/L) histidine and methionine 
for 72 h at 30°C with shaking in 96-deep-well plates with breathable sealing film. The 
cells were then concentrated by centrifugation at 1,500 × g for 5 min, and were 
inoculated into SD, SX, or SDX2 selective media in 96-deep-well plates with 
non-porous seals (PCR-SPS, BMBio) (OD600 = 0.5~0.8). Cells were grown at 30°C by 
shaking at 1,200 rpm. 
 
β-galactosidase activity assays 
Promoter activity was measured according to the previously described method 
(Partow et al. 2010) with slight modification. 0.1 mL of yeast cell culture was mixed 
with 0.4 mL Z buffer (45 mM Na2HPO4, 35 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4), 
25 µL 0.1% (w/v) SDS, and 50 µL chloroform in a 96-deep-well plate. The reaction was 
started through the addition of 0.2 mL of 4 mg/mL o-nitrophenyl-β-D-galactopyranoside 
(ONPG) solution at 28°C and stopped through the addition of 0.5 mL of 1 M NaCO3. 
After removal of cell debris by centrifugation, ABS420 and ABS550 were measured with a 
spectrophotometer (UV-mini 1240, Shimadzu). β-galactosidase activity was determined 
as Miller units according to the following equation: 
Miller units = 1000×[ABS420 – (1.75×ABS550)] / (t×V×ABS660) (1) 
 
where t represents the reaction time in minutes and V the culture volume (mL) used in 
the assay. 
 
Accession number 
Microarray data analyzed in this study have been deposited in the Gene Expression 
Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) and were assigned series record 
GSE97580. 
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Results and Discussions 
Microarray analyses in xylose- and glucose-fermentation conditions  
The xylose-utilizing S. cerevisiae strain BY4741/X-I2 was constructed by 
introducing the XYL1 and XYL2 genes from S. stipitis (encoding XR and XDH) and the 
endogenous XKS1 gene from S. cerevisiae (encoding XK) into the genome of BY4741 
(Table 1). Ethanol fermentations under microaerobic (oxygen-limited) conditions were 
tested using BY4741/X-I2 in YP rich media containing xylose and glucose as respective 
sole carbon sources (Figure 1). BY4741/X-I2 consumed 49 g/L xylose and produced 12 
g/L ethanol and 15 g/L xylitol after a 24 h fermentation (Figure 1A), while it completely 
consumed 50 g/L glucose and produced 23 g/L ethanol after a 6 h fermentation (Figure  
1B). To obtain microarray samples in the representative cell growth condition, the times 
to consume half the carbon sources were determined as approximately 9 h and 3 h in 
xylose- and glucose-fermentations, respectively. Microaerobic fermentation condition 
was selected with applications in mind. 
At the above determined time points, total RNAs were extracted from the yeast 
cells and their gene expressions were analyzed by DNA microarray. The microarray data 
for the values of normalized signals (at the 75th percentile of raw signal values; log2) 
both during xylose and glucose fermentations have been deposited to GEO (Accession 
No. GSE97580). 
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Figure 1 Time-course profiles of ethanol fermentations under microaerobic 
conditions using the xylose-utilizing BY4741/X-I2 yeast strain. 
Fermentations were performed in YP-rich media containing (A) 50 g/L xylose and (B) 
50 g/L glucose. Concentrations of each compound were measured by HPLC. Closed 
diamonds, glucose; closed squares, xylose; closed triangles; ethanol, open circles, 
xylose; crosses, glycerol. Data represent three independent experiments ± SD. 
 
 
Selection of promoter candidates for xylose fermentation  
Table 4 and Figure 2 show some of the normalized values of the microarray data, 
which are mainly focused on central metabolism. Similar to glucose fermentation, many 
genes serve as glycolysis factors, ethanol biosynthesis, and translational elongation 
factors displayed high normalized signal values during xylose fermentation (e.g. FBA1, 
TDH1, PDC1, ADH1, and TEF1) (Table 4 and Figure 2; red columns). In contrast, 
genes serving as PPP factors, hexose transporters, pyruvate dehydrogenases, and 
aldehyde dehydrogenases showed moderate (e.g. NQM1, GND1, HXT7, and ALD4) 
(Table 4 and Figure 2; orange columns) or weak (e.g. RKI1, HXT2, HXT8, and PDA1) 
(Table 4 and Figure 2; yellow columns) normalized signals during xylose fermentation. 
Interestingly, NQM1 and GND2 genes showed substantially higher expression with 
xylose than glucose. HXT3, HXT4, and HXK2 genes showed much lower expression 
with xylose than glucose (Figure 2).  
To assess whether the promoters are available for xylose cultivation and 
fermentation, 29 genes (30 promoters; includes one gene reported to have two different 
lengths as promoter regions) that showed various expression levels in xylose 
fermentation were chosen mainly from central metabolic pathways (Table 4 and Figure 
2; red, orange, and yellow columns). 
 
Measurements of promoter activities with xylose and glucose under aerobic and 
microaerobic conditions over time 
Along with the SAG1 terminator (TSAG1) (Yamanishi et al. 2013), the lacZ gene was 
inserted into the multi-cloning site of a single-copy pRS415 vector, yielding 
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pRS415/lacZ-TSAG1 control plasmid (Table 1). The 30 selected promoters (Table 2) were 
then connected to the upstream of lacZ gene, generating pRS415/Pxxxx-lacZ-TSAG1 (Pxxxx: 
xxxx promoter) (Table 1). The BY4741/X-I2 yeast strain was transformed with plasmid 
pRS415/Pxxxx-lacZ-TSAG1, yielding BY4741/X-I2-Pxxxx. A control strain, BY4741/X-I2-C, 
was obtained by the transformation of BY4741/X-I2 with pRS415/lacZ-TSAG1 (Table 1).  
The transformants were cultured respectively in synthetic xylose and glucose 
media under aerobic and microaerobic conditions. Cells were inoculated into synthetic 
media in 96-deep-well plates at low turbidity for aerobic cultivations (for glucose: 
OD600 ≤ 0.12; for xylose: OD600=0.1~0.2) and at moderate turbidity for microaerobic 
fermentations (for glucose and xylose: OD600 = 0.5~0.8). To evaluate the activities of 
candidate promoters, cells were sampled over time and β-galactosidase assays using 
lacZ genes were performed. The promoter activities measured are shown in Table 5 as a 
heat map. Time-courses of promoter activities under each condition are displayed in 
Figure 3.  
Because each probe of microarray has a different annealing efficiency, the 
normalized signal intensities obtained using the 75th percentile procedure should be 
generally unavailable for relative comparison. However, comparing the data shown in 
Table 4 (microarray data) and Table 5 (promoter activities), the order of promoter 
activities roughly correlated with that of the normalized signals in the gene expression 
analysis. This indicated that a combination of microarray data and reporter gene assays 
is a useful approach to choose candidate promoters that function in desired culture 
conditions, although the promoter activities must be carefully checked. 
  
24 
 
Table 4 Standard deviation of microarray data about pick up promoter 
 
 
 
 
 
 
 
 
Xylose Glucose 
 Gene 
n=1 n=2 n=3 Average SD n=1 n=2 n=3 Average SD 
Probe 
Symbol Name 
ADH1 7.07 7.62 7.41 7.37 0.28 6.71 5.61 8.48 6.93 1.45 A_06_P6278 
SED1 6.85 7.08 7.02 6.98 0.12 6.21 6.38 6.86 6.48 0.34 A_06_P6281 
TDH1 6.53 6.98 7.05 6.85 0.29 6.45 6.23 6.79 6.49 0.28 A_06_P6280 
FBA1 6.31 6.60 6.27 6.39 0.18 6.39 6.42 6.68 6.49 0.16 A_06_P6279 
CDC19 5.61 5.68 6.12 5.81 0.28 5.94 6.00 6.46 6.13 0.29 A_06_P1062 
PDC1 5.53 5.72 6.04 5.77 0.25 5.95 6.46 6.67 6.36 0.37 A_06_P4856 
PGK1 5.44 5.37 6.42 5.74 0.58 5.67 5.00 6.21 5.63 0.61 A_06_P1633 
TPI1 5.54 5.51 5.92 5.66 0.23 6.03 5.49 6.22 5.92 0.38 A_06_P2037 
TEF1 5.21 5.30 6.27 5.59 0.58 5.13 4.86 6.16 5.39 0.68 A_06_P7127 
TEF2 5.07 5.09 6.41 5.52 0.77 5.10 4.68 6.70 5.49 1.06 A_06_P1370 
ALD4 4.25 4.65 5.21 4.70 0.48 2.96 2.14 3.31 2.81 0.6 A_06_P6738 
TDH3 4.37 4.43 4.96 4.59 0.32 4.65 4.23 5.40 4.76 0.6 A_06_P3413 
GND1 4.08 4.04 4.82 4.31 0.44 4.22 2.26 4.67 3.72 1.28 A_06_P3761 
HXT7 4.07 4.16 3.90 4.04 0.13 4.81 1.20 5.52 3.84 2.32 A_06_P2333 
NQM1 3.34 3.46 3.90 3.56 0.29 1.89 0.83 1.87 1.53 0.61 A_06_P3263 
LPD1 3.29 3.36 3.39 3.35 0.05 3.33 2.70 3.44 3.15 0.4 A_06_P2844 
ADH3 2.95 2.83 3.85 3.21 0.56 3.04 2.19 3.85 3.03 0.83 A_06_P5511 
GND2 2.94 2.98 3.29 3.07 0.19 2.25 1.47 2.60 2.11 0.58 A_06_P3477 
LAT1 2.89 2.80 2.86 2.85 0.04 3.46 2.43 3.31 3.07 0.56 A_06_P5842 
PDA1 2.36 2.40 2.25 2.34 0.08 2.69 2.34 2.43 2.49 0.18 A_06_P2810 
SOL4 2.07 2.12 2.41 2.20 0.18 2.21 0.74 2.16 1.70 0.83 A_06_P3469 
ALD3 1.79 1.99 1.39 1.72 0.3 1.15 -0.03 0.75 0.62 0.6 A_06_P5604 
ZWF1 1.11 1.31 0.95 1.13 0.18 -0.11 1.75 -0.51 0.38 1.2 A_06_P6013 
PDC6 0.55 0.63 0.60 0.59 0.04 -2.07 -0.07 -2.17 -1.44 1.18 A_06_P3307 
TKL2 -0.06 0.16 0.12 0.07 0.12 -1.49 -1.97 -1.47 -1.64 0.28 A_06_P1369 
HXT2 -1.06 -0.50 -0.23 -0.60 0.42 -1.94 -1.34 -1.59 -1.62 0.3 A_06_P5438 
RKI1 -2.70 -2.77 -2.21 -2.56 0.31 -2.68 -3.30 -1.97 -2.65 0.67 A_06_P6457 
STB5 -3.60 -3.55 -4.10 -3.75 0.3 -3.91 -2.83 -4.41 -3.72 0.81 A_06_P3756 
HXT8 -4.49 -5.07 -4.26 -4.61 0.42 -5.08 -4.56 -4.53 -4.72 0.31 A_06_P4236 
 
Xylose [log2] 
  >5.0 
  3.0 - 5.0 
  Below 3.0 
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Figure 2 Normalized signals of gene expression in central carbon metabolism.  
Microarray analyses were performed using the BY4741/X-I2 strain fermented in YP 
xylose and glucose media. Total RNAs were extracted from the yeast cells at the times 
at which half of the carbon source was consumed (9 h and 3 h for xylose- and 
glucose-fermentations, respectively). Normalized signal intensities (log2: xylose vs. 
glucose) of microarray data using the 75th percentile normalization procedure are 
indicated. Genes marked in bold were subjected to β-galactosidase assays. 
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Figure 3 Time-course profiles of 30 promoter activities measured in different 
culture conditions. 
(A) Aerobic cultivation and (B) microaerobic fermentation conditions in xylose media. 
(C) Aerobic cultivation and (D) microaerobic fermentation conditions in glucose media. 
β-galactosidase activities of BY4741/X-I2-Pxxxx (harboring pRS415/Pxxxx-lacZ-TSAG1) at 
each time point are indicated. Data represent three independent experiments ± SEM. 
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Table 5 Heatmap list of relative promoter activities during aerobic cultivations and microaerobic fermentations in xylose and 
glucose media 
 
 
 
 
 
 
 
 
 
Xylose Glucose 
 
Aerobic cultivation Microaerobic fermentation Aerobic cultivation Microaerobic fermentation 
 
24 h 48 h 72 h 96 h 6 h 24 h 48 h 72 h 12 h 24 h 48 h 72 h 6 h 24 h 30 h 48 h 
Control 0.00 0.19 0.01 0.00 0.06 0.00 0.00 0.00 1.95 0.27 2.48 0.64 0.00 0.00 0.01 0.02 
TDH3 439.42 679.27 564.89 429.42 230.34 191.18 142.83 93.10 340.00 423.40 413.97 335.33 233.14 210.19 239.56 10.38 
FBA1 232.16 488.02 345.99 326.68 72.46 62.44 91.39 12.86 92.71 206.17 174.61 104.12 84.41 241.24 117.14 15.07 
TDH1 398.84 287.94 367.94 222.94 239.54 158.52 118.21 73.32 78.84 268.46 220.94 157.36 23.43 181.93 187.87 121.99 
SED1b 158.97 190.67 161.03 258.32 22.02 23.10 24.60 39.89 207.29 264.89 58.13 36.09 15.68 130.93 113.05 45.50 
HXT7 147.08 220.94 173.21 193.03 19.36 19.67 28.65 31.49 74.59 98.75 139.37 82.02 12.97 40.69 71.63 9.29 
PDC1 160.49 211.29 166.53 141.35 43.98 25.79 24.47 17.14 208.23 273.04 79.59 52.00 88.94 156.56 121.06 6.36 
TEF1 161.39 207.54 135.36 93.13 44.32 39.24 46.37 34.82 110.11 134.12 206.17 139.03 58.10 121.56 181.02 20.24 
TPI1 189.70 126.11 173.70 83.59 76.11 47.89 40.07 30.34 34.57 80.80 95.99 55.82 63.97 182.38 96.78 3.88 
PGK1 161.46 80.75 130.79 83.14 38.95 23.99 23.03 19.17 62.58 118.08 180.44 167.99 40.20 99.49 69.31 16.24 
SED1a 122.39 151.27 113.69 82.14 19.63 10.91 8.32 8.03 73.50 174.81 180.75 102.51 40.74 150.90 216.27 16.79 
ADH1 140.35 131.83 108.11 39.85 46.14 43.05 25.10 18.61 42.40 46.96 45.96 49.09 46.32 44.78 43.99 3.73 
PDC6 26.11 98.67 118.86 129.73 3.37 3.23 4.04 6.71 57.02 90.53 35.09 25.17 1.29 8.44 13.01 4.73 
GND1 71.28 113.86 124.32 67.24 49.47 47.62 45.53 25.49 87.54 177.75 47.06 20.71 37.40 77.71 53.26 11.28 
CDC19 110.53 70.37 58.91 21.59 30.13 20.06 12.14 17.07 39.54 37.98 43.49 32.47 55.98 53.48 42.23 3.35 
TEF2 78.76 97.11 92.79 74.05 20.53 13.07 11.02 8.58 72.62 148.89 197.42 131.35 32.62 100.87 135.05 18.63 
  > 300 miller units 
  200 - 300 miller units 
  100 - 200 miller units 
  20 - 100 miller units 
  5 - 20 miller units 
  Below 5 miller units 
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ZWF1 32.06 51.80 47.82 78.96 6.47 7.06 6.60 10.90 25.19 41.00 8.60 5.15 0.89 13.96 7.68 6.01 
ALD4 51.04 69.45 53.96 45.19 1.10 2.39 4.71 6.10 35.10 62.72 9.12 5.05 0.58 18.08 22.83 6.21 
ALD3 23.77 45.16 36.77 24.34 1.57 0.98 3.78 0.81 10.96 35.85 42.29 45.01 0.75 5.03 0.96 0.67 
TKL2 14.88 29.31 21.20 23.49 0.07 0.52 0.65 1.84 0.17 9.46 12.15 7.18 0.05 0.27 5.08 2.13 
SOL4 17.81 24.39 14.26 13.66 8.87 6.04 5.82 3.42 8.79 18.61 28.52 25.74 8.66 11.38 7.29 1.49 
ADH3 9.44 17.21 7.73 0.06 1.26 1.24 0.09 0.08 9.22 15.18 14.75 12.76 5.98 10.08 5.98 0.05 
GND2 4.84 8.58 11.69 5.87 0.00 0.09 0.00 0.47 0.00 5.10 0.28 1.29 0.00 0.60 0.00 0.41 
HXT2 8.74 7.55 0.81 3.28 1.16 0.59 0.34 0.06 2.90 4.92 2.32 1.28 0.33 1.01 0.07 0.31 
RKI1 3.19 5.66 0.75 7.08 0.00 0.00 0.00 0.00 0.17 0.26 4.10 0.67 0.00 0.02 0.10 0.03 
PDA1 3.33 6.90 4.28 1.78 2.94 2.94 0.70 0.00 2.07 11.14 7.47 5.50 3.51 4.23 3.88 0.31 
NQM1 0.87 0.20 0.32 6.30 0.00 0.00 0.00 0.00 0.00 0.69 0.05 0.00 0.00 0.00 2.43 1.05 
STB5 1.21 4.05 5.93 0.00 0.00 0.00 0.00 0.06 0.00 0.64 0.00 0.80 0.00 0.90 0.00 0.09 
LPD1 1.26 4.88 2.55 0.38 0.13 0.38 0.16 0.00 0.29 3.35 3.78 4.09 0.19 0.15 0.23 0.08 
HXT8 2.64 3.65 0.59 4.60 0.00 0.00 0.00 0.00 1.16 0.51 0.10 0.53 0.21 0.00 0.00 0.10 
LAT1 0.30 0.15 0.47 0.00 0.27 0.16 0.00 0.00 0.12 0.26 0.14 0.39 0.40 0.86 0.24 0.02 
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Promoters for high expression in xylose media both during aerobic and 
microaerobic conditions 
In xylose media, most of selected promoters showed higher activities under aerobic 
conditions than microaerobic (oxygen-limited) conditions (Figure 3A and 3B). A similar 
trend was also observed in glucose media (Figure 3C and 3D). The orders of promoter 
activities were largely consistent between aerobic and microaerobic conditions both in 
xylose (Figure 3A and 3B) and glucose media (Figure 3C and 3D). 
PTDH3, PFBA1, and PTDH1 showed the highest promoter activities both in aerobic and 
microearobic conditions in xylose media, although PFBA1 in microaerobic conditions 
exhibited lower activity compared to the other two promoters (Figure 4). These three 
promoters also showed extremely high activities in glucose media (Figure 4). PTDH3 is 
well known as one of the strongest promoters and is widely used in S. cerevisiae (Ishii 
et al. 2014). Although PFBA1 and PTDH1 are less common as promoters for heterologous 
gene expression in S. cerevisiae, they would be user-friendly for use both in glucose and 
xylose media, similar to PTDH3. When limited to aerobic conditions, the promoter 
activities of PTDH3, PFBA1, and PTDH1 cultured in xylose media were interestingly higher 
than those cultured in glucose media (Figure 4).In particular, PFBA1 showed much higher 
activity in xylose than in glucose. In a previous study, the FBA1 promoter showed no 
significant difference in activity between glucose medium and glycerol/ethanol medium 
under aerobic cultivation (Compagno et al. 1991). The activity of PFBA1 is thus possibly 
enhanced by xylose metabolism. 
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Figure 4 Time-course profiles of promoter activities (TDH3, FBA1, and TDH1) 
during aerobic cultivations and microaerobic fermentations in xylose and glucose 
media. 
These promoters (TDH3, FBA1, and TDH1) showed high expressions both under 
aerobic and microaerobic conditions in xylose media. β-galactosidase activities of 
BY4741/X-I2-Pxxxx (harboring pRS415/Pxxxx-lacZ-TSAG1) at each time point are indicated. 
Data represent three independent experiments ± SEM. 
 
 
Promoters for medium-high and moderate expressions in xylose media respectively 
during aerobic and microaerobic conditions 
PPDC1, PTEF1, PTPI1, and PPGK1 serve as promoters for genes for ethanol biosynthesis, 
translational elongation, and glycolysis, and are also often used for engineered gene 
expression (Sun et al. 2012; Ishii et al. 2014; Guo et al. 2016). Hxt7p, a high-affinity 
glucose transporter, has been reported to be an important xylose-transporting protein 
among the 18 hexose-transporters (Hamacher et al. 2002). Sed1p is a major 
stress-induced structural glycoprotein that exists abundantly on yeast cell walls 
(Inokuma et al. 2014). Two different lengths of PSED1 have been reported as promoter 
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regions: one 1063 bp and the other 800 bp (designated as PSED1a and PSED1b, 
respectively) (Kotaka et al. 2010; Tanino et al. 2007). These seven promoters were 
available as medium-high expression promoters during aerobic cultivations both in 
glucose and xylose media (Figure 5). In contrast, the activities of these promoters 
during microaerobic fermentation in xylose media were modest and weaker than 
expected, even though most of them showed medium-high expression in glucose 
fermentation (Figure 5). PHXT7 exhibited comparatively lower promoter activity during 
glucose fermentation (Figure 5). In comparing different length SED1 promoters, the 
shorter version (PSED1b) showed higher maximum activity compared to the longer 
version (PSED1a), except in microaerobic glucose fermentation (Table 5 and Figure 5).  
 
Other promoters for moderate or weak expression in xylose media 
PADH1, PGND1, PPDC6, and PCDC19 showed comparatively high promoter activities 
during aerobic xylose cultivation (Figure 6). Among them, PADH1 and PGND1 showed 
moderate promoter activities during microaerobic xylose fermentation (Figure 6). 
PCDC19 and PPDC6 respectively showed weak and almost no activity in lacZ reporter 
assays during microaerobic fermentation both in xylose and glucose media (Figure 6). 
During both aerobic cultivation and microaerobic fermentation in glucose media, PGND1 
displayed moderate promoter activities during glucose cultivation and fermentation, 
while the other promoters showed relatively weak activities (Figure 6). PTEF2 showed 
moderate promoter activity during aerobic xylose cultivation, although it exhibited 
weak activity during microaerobic xylose fermentation (Figure 6). In contrast, PTEF2 
showed medium-high promoter activities both during cultivation and fermentation 
conditions in glucose media (Figure 6).  
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Figure 5 Time-course profiles of promoter activities (SED1b, HXT7, PDC1, TEF1, 
TPI1, PGK1, and SED1a) during aerobic cultivations and microaerobic 
fermentations in xylose and glucose media. 
These promoters (SED1b, HXT7, PDC1, TEF1, TPI1, PGK1, and SED1a) showed 
medium-high and moderate expressions respectively under aerobic and microaerobic 
conditions in xylose media. β-galactosidase activities of BY4741/X-I2-Pxxxx (harboring 
pRS415/Pxxxx-lacZ-TSAG1) at each time point are indicated. Data represent three 
independent experiments ± SEM. 
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Figure 6 Time-course profiles of promoter activities (ADH1, PDC6, GND1, CDC19, 
and TEF2) during aerobic cultivations and microaerobic fermentations in xylose 
and glucose media. 
These promoters (ADH1, PDC6, GND1, CDC19, and TEF2) showed moderate or weak 
expression under aerobic and microaerobic conditions in xylose media. β-galactosidase 
activities of BY4741/X-I2-Pxxxx (harboring pRS415/Pxxxx-lacZ-TSAG1) at each time point 
are indicated. Data represent three independent experiments ± SEM. 
 
 
PZWF1 and PSOL4 displayed moderate promoter activities during aerobic cultivations, 
and considerably weak but definite promoter activities during microaerobic 
fermentations both in xylose and glucose media (Figure 7). PALD4, PALD3, and PTKL2 
showed moderate promoter activities during aerobic cultivations in both xylose and 
glucose media, whereas they showed almost no activities in microaerobic fermentations 
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except for PALD4 in glucose media (Figure 7). PADH3, PGND2, PHXT2, PRKI1, and PPDA1 
showed considerably weak promoter activities during aerobic cultivation both in xylose 
and glucose media, and they showed almost no activities in microaerobic fermentations 
(Figure 8). Other promoters showed no activity during either aerobic cultivations or 
microaerobic fermentations in either xylose or glucose media (Figure 8). 
 
 
Figure 7 Time-course profiles of promoter activities (ZWF1, ALD4, ALD3, TKL2, 
and SOL4) during aerobic cultivations and microaerobic fermentations in xylose 
and glucose media. 
These promoters (ZWF1, ALD4, ALD3, TKL2, and SOL4) showed moderate or 
considerably weak expression under aerobic and microaerobic conditions in xylose 
media. β-galactosidase activities of BY4741/X-I2-Pxxxx (harboring 
pRS415/Pxxxx-lacZ-TSAG1) at each time point are indicated. Data represent three 
independent experiments ± SEM. 
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Figure 8 Time-course profiles of promoter activities (ADH3, GND2, HXT2, RKI1, 
PDA1, NQM1, STB5, LPD1, HXT8, and LAT1) promoters during aerobic 
cultivations and microaerobic fermentations in xylose and glucose media. 
These promoters (ADH3, GND2, HXT2, RKI1, PDA1, NQM1, STB5, LPD1, HXT8, and 
LAT1) showed considerably weak or almost no expression under aerobic and 
microaerobic conditions in xylose media. β-galactosidase activities of 
BY4741/X-I2-Pxxxx (harboring pRS415/Pxxxx-lacZ-TSAG1) at each time point are indicated. 
Data represent three independent experiments ± SEM.
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Figure 9 Time-course profiles of activities of representative promoters during 
aerobic cultivations and microaerobic fermentations in synthetic media containing 
both glucose and xylose. 
The promoters, which have showed (A) high expression, (B) moderate expression, (C) 
weak expression, and (D) considerably weak or almost no expression in xylose media 
under microaerobic fermentation, were selected for the assays. β-galactosidase activities 
of BY4741/X-I2-Pxxxx (harboring pRS415/Pxxxx-lacZ-TSAG1) at each time point are 
indicated. Data represent three independent experiments ± SEM. 
 
 
Measurements of activities for representative promoters in media containing both 
xylose and glucose during aerobic and microaerobic conditions 
The activities of several representative promoters were further investigated in 
synthetic media containing both glucose and xylose. The transformants were cultured 
respectively in glucose/xylose mixed media under aerobic and microaerobic conditions, 
and the β-galactosidase assays were performed (Figure 9). As a consequence of the 
assays, most of promoters examined basically showed similar trends of the promoter 
activities to the cultures in xylose or glucose media (Figure 9A~D).  
It has demonstrated that the use of high expression promoters for all of genes does 
not necessarily result in the best efficiency, and the combinatorial expression 
approaches are helpful to determine optimal expression profiles (Latimer et al. 2014; Ito 
et al. 2015). For instance, it is important to optimize the expression levels of a series of 
genes involved in the metabolic pathways such as xylose assimilation (XR, XDH, and 
XK) and PPP (e.g., RPE, RKI, TKL, and TAL) for effective xylose utilization in S. 
cerevisiae. Whereas high expression promoters were favorable for XR and TAL, 
medium or low expression promoters were suitable for other genes especially in 
micoaerobic condition (Latimer et al. 2014). As another example, tuning copy numbers 
for three cellulase genes using different sets of promoters and terminators enabled 
optimization of the degradation ability for Avicel cellulose, conducting higher ethanol 
production level than the previous constructed strains (Ito et al. 2015). Thus, the results 
of promoter activities in glucose/xylose mixed media suggested that accumulating the 
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knowledge of promoters would be useful to make the engineered strains for cultivation 
or fermentation using hemicellulosic biomass as the carbon source. 
In conclusion, by reference to normalized signal values of microarray data, 
candidate promoters were selected and their activities were measured using lacZ 
reporter gene assays. The promoter activities were quite different depending on the 
culture conditions, indicating the need for a great deal of attention in promoter selection. 
The knowledge of promoter activity in xylose cultivation and fermentation obtained in 
this study will allow for the control of gene expression in engineered xylose-utilizing 
yeast strains used in hemicellulose fermentation. 
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Chapter 2 
Development of a comprehensive set of tools for genome engineering in a cold- and 
thermo-tolerant Kluyveromyces marxianus yeast strain 
 
Introduction 
The non-conventional yeast Kluyveromyces marxianus is known to be 
thermotolerant and Crabtree-negative. The latter term indicates that this species 
produces ethanol only under anaerobic conditions (Nonklang et al. 2008); in contrast, 
Crabtree-positive yeasts such as Saccharomyces cerevisiae obligately produce ethanol 
both aerobically and anaerobically. Thus, Crabtree-negative yeasts are more suitable for 
the generation of various products other than ethanol because these strains do not 
undergo aerobic alcoholic fermentation, which consumes carbon resources (Wagner and 
Alper 2016). The thermotolerance of K. marxianus also allows faster growth and 
production at higher temperatures, and some volatile products can be collected during 
synthesis more efficiently at higher temperature. Another benefit of the faster growth of 
K. marxianus at 37°C is the ability to obtain single colonies after overnight incubation, 
while generally used S. cerevisiae strains take 2 to 3 days at 30°C. Recently, the 
complete genome sequence for K. marxianus has been reported (Jeong et al. 2012; 
Suzuki et al. 2014; Inokuma et al. 2015).
 
 
Unlike S. cerevisiae, which demonstrates homologous recombination (HR) of 
transformed DNA, K. marxianus DMKU3-1042 tends to integrate DNA fragments 
randomly into its genome (Nonklang et al. 2008). Such random integration is attributed 
to the high activity of the non-homologous end-joining (NHEJ) pathway (Abdel-Banat 
et al. 2009). K. marxianus NBRC1777 reportedly needed relatively large homology 
arms (641 and 1475 bp) of flanking DNA for insertion by HR (Hong et al. 2007), while 
S. cerevisiae requires only ~50-bp homology arms, sequence lengths that can be added 
at the 5’ ends of PCR primers (Da Silva and Srikrishnan 2012).  
Disruption of the NHEJ pathway in yeasts has been shown to suppress random 
integration events and therefore increase the success rate of HR in these organisms 
(Abdel-Banat et al. 2009; Valencia et al. 2001). The core NHEJ proteins are Ku70/Ku80, 
Lig4/Lif1, and Nej1 (Dudášová et al. 2004; Feldmann and Winnacker 1993; Feldmann 
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et al. 1996; Moore and Haber 1996). In the first step, a stable heterodimer of 
Ku70/Ku80 binds to broken DNA ends and acts as a bridging complex. Lig4 and Lif1 
also form a highly stable complex. Lig4 is an ATP-dependent double-strand break 
(DSB) repair DNA ligase and Lif1 is Lig4’s stabilizing, stimulating, and targeting 
co-factor (Dudášová et al. 2004). In S. cerevisiae, deletion of NEJ1 reduces NHEJ by 
100-fold (Valencia et al. 2001).  
Clustered regularly interspaced short palindromic repeats (CRISPR) associated 
proteins (CRISPR-Cas9) genome-editing tools have been applied in several yeast 
species, facilitating NHEJ-mediated insertion/deletion formation. HR-mediated 
integration following CRISPR-Cas9 editing has also been demonstrated, with efficiency 
varying depending on the yeast species (Wagner and Alper 2016; Jakočiūnas et al. 2016). 
More recently, deaminase-mediated targeted point mutagenesis (Target-AID) has been 
performed in S.cerevisiae; which is a hybrid system of nuclease-deficient CRISPR-Cas9 
and activation-induced cytidine deaminase (AID) (Nishida et al. 2016). When AID 
ortholog PmCDA1 was fused to C-terminus of nickase Cas9(D10A), C to T/G point 
mutation was induced within 3-5 bases window at the 5’ end of target sequence.  
Target-AID also appeared to be much less toxic compared to CRISPR-Cas9. 
Here, we describe the development of a comprehensive set of genome engineering 
tools for use with K. marxianus NBRC1777, a strain that we show to be both cold- and 
thermo-tolerant. 
 
 
Materials and Methods 
Strains and culture conditions 
S. cerevisiae and K. marxianus strains used in this study are listed in Table 1. Yeast 
cells were grown in YPD medium (10 g/L yeast extract, 20 g/L peptone, and 20 g/L 
glucose) at 30°C unless otherwise noted. Escherichia coli strain DH5α (Toyobo, Osaka, 
Japan) which was used for cloning, was grown in Luria-Bertani (LB) medium (10 g/L 
peptone, 5 g/L yeast extract, and 5 g/L sodium chloride) supplemented with 100 mg/L 
ampicillin at 37°C. 
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Table 1 Plasmids and strains used in this study. 
Plasmids and strains Genotype Reference 
Plasmids 
  
nCas9-CDA_Base ScPPDC1_nCas9_TTDH3, KmARS7, Km CEN D, kanMX, ori, and AmpR This study 
nCas9-CDA_target Nej1 KmPSNR52_target_Nej1_sgRNA_Tsup4 cassette in nCas9-CDA_Base This study 
nCas9-CDA_target Dnl4 KmPSNR52_target_Dnl4_sgRNA_Tsup4 cassette in nCas9-CDA_Base This study 
Cas9_Base ScPPDC1_Cas9_TTDH3, KmARS7, Km CEN D, kanMX, ori, and AmpR This study 
Cas9_Base_target_Ura3_Fw KmPSNR52_target_Ura3_Fw_sgRNA_Tsup4 cassette in Cas9_Base This study 
Cas9_Base_target 
_Ura3_Fw+Rv 
KmPSNR52_target_Ura3_Fw_sgRNA_Tsup4 cassette and 
KmPSNR52_target_Ura3_Rv_sgRNA_Tsup4 cassette in Cas9_Base 
This study 
Cas9_Base_target Sed1 KmPSNR52_target_Sed1_sgRNA_Tsup4 cassette in Cas9_Base This study 
TOPO/F7 ScPPDC1_EGFP_bleomycin on both sides Ura3 homologous sequence 
cassette in pCR
TM
4Blunt-TOPO
®
 
This study 
   
Strains 
  
S. cerevisiae 
  
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ATCC 
   
K. marxianus 
  
NBRC1777 Wild-type 
NITE Biological Resource 
Center, Japan 
Nej1º Nej1disrupted by C to T point mutation at position 13 This study 
Dnl4º Dnl4 disrupted by G to A point mutation at position 44 This study 
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Growth measurements 
S. cerevisiae BY4741 and K. marxianus NBRC1777 strains were grown in YPD 
medium overnight at 30°C by shaking in test tubes. The cells were inoculated into 5 mL 
of YPD medium at a starting optical density at 600 nm (OD600) of 0.05, and cultures 
were cultivated at 5, 10, 20, 30, 37, or 45°C. Cell growth was tracked by measuring 
OD600 using a UV mini spectrophotometer (Shimadzu, Kyoto, Japan). The µmax was 
determined as the slope of the log phase of natural logarithm (ln) transformation of the 
linear region. 
 
Construction of basal genome-editing plasmids  
The vector sequences are provided in Figure 1 and 2. Vector assembly was 
performed by PCR using the In-fusion cloning method (Takara Bio, Shiga, Japan). The 
vector backbone was designed to contain KmARS7, KmCEN-D and selectable marker 
kanMX, which encodes G418 resistance. For CRISPR-Cas9 (Cas9_Base) and 
Target-AID (nCas9-CDA_Base) vectors, a gene encoding human-optimized 
nCas9-PmCDA1 or Cas9 (Nishida et al. 2016; Dicarlo et al.2013) (respectively) was 
placed between ScPPDC1 and the TDH3 terminator (ScTTDH3) on the vector backbone.  
 
AAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCA
CCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGAACCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGC
CAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCT
AGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTT
TGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTA
GCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAAT
TCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTAT
GCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCA
TTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCA
CCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAA
GGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATT
GTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGTTAATTAATTGAGATAAGC
ACACTGCACCCATACCTTCCTTAAAAACGTAGCTTCCAGTTTTTGGTGGTTCCGGCTTCCTTCCCGATTCCGCCCGCTAA
ACGCATATTTTTGTTGCCTGGTGGCATTTGCAAAATGCATAACCTATGCATTTAAAAGATTATGTATGCTCTTCTGACTT
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TTCGTGTGATGAGGCTCGTGGAAAAAATGAATAATTTATGAATTTGAGAACAATTTTGTGTTGTTACGGTATTTTACTAT
GGAATAATCAATCAATTGAGGATTTTATGCAAATATCGTTTGAATATTTTTCCGACCCTTTGAGTACTTTTCTTCATAAT
TGCATAATATTGTCCGCTGCCCCTTTTTCTGTTAGACGGTGTCTTGATCTACTTGCTATCGTTCAACACCACCTTATTTT
CTAACTATTTTTTTTTTAGCTCATTTGAATCAGCTTATGGTGATGGCACATTTTTGCATAAACCTAGCTGTCCTCGTTGA
ACATAGGAAAAAAAAATATATAAACAAGGCTCTTTCACTCTCCTTGCAATCAGATTTGGGTTTGTTCCCTTTATTTTCAT
ATTTCTTGTCATATTCCTTTCTCAATTATTATTTTCTACTCATAACCTCACGCAAAATAACACAGTCAAATCAATCAAAG
CTAGCGAAATGGCACCGAAGAAGAAGCGTAAAGTCGGAATCCACGGAGTTCCTGCGGCAATGGACAAGAAGTACTCCATT
GGGCTCGATATCGGCACAAACAGCGTCGGTTGGGCCGTCATTACGGACGAGTACAAGGTGCCGAGCAAAAAATTCAAAGT
TCTGGGCAATACCGATCGCCACAGCATAAAGAAGAACCTCATTGGCGCCCTCCTGTTCGACTCCGGGGAGACGGCCGAAG
CCACGCGGCTCAAAAGAACAGCACGGCGCAGATATACCCGCAGAAAGAATCGGATCTGCTACCTGCAGGAGATCTTTAGT
AATGAGATGGCTAAGGTGGATGACTCTTTCTTCCATAGGCTGGAGGAGTCCTTTTTGGTGGAGGAGGATAAAAAGCACGA
GCGCCACCCAATCTTTGGCAATATCGTGGACGAGGTGGCGTACCATGAAAAGTACCCAACCATATATCATCTGAGGAAGA
AGCTTGTAGACAGTACTGATAAGGCTGACTTGCGGTTGATCTATCTCGCGCTGGCGCATATGATCAAATTTCGGGGACAC
TTCCTCATCGAGGGGGACCTGAACCCAGACAACAGCGATGTCGACAAACTCTTTATCCAACTGGTTCAGACTTACAATCA
GCTTTTCGAAGAGAACCCGATCAACGCATCCGGAGTTGACGCCAAAGCAATCCTGAGCGCTAGGCTGTCCAAATCCCGGC
GGCTCGAAAACCTCATCGCACAGCTCCCTGGGGAGAAGAAGAACGGCCTGTTTGGTAATCTTATCGCCCTGTCACTCGGG
CTGACCCCCAACTTTAAATCTAACTTCGACCTGGCCGAAGATGCCAAGCTTCAACTGAGCAAAGACACCTACGATGATGA
TCTCGACAATCTGCTGGCCCAGATCGGCGACCAGTACGCAGACCTTTTTTTGGCGGCAAAGAACCTGTCAGACGCCATTC
TGCTGAGTGATATTCTGCGAGTGAACACGGAGATCACCAAAGCTCCGCTGAGCGCTAGTATGATCAAGCGCTATGATGAG
CACCACCAAGACTTGACTTTGCTGAAGGCCCTTGTCAGACAGCAACTGCCTGAGAAGTACAAGGAAATTTTCTTCGATCA
GTCTAAAAATGGCTACGCCGGATACATTGACGGCGGAGCAAGCCAGGAGGAATTTTACAAATTTATTAAGCCCATCTTGG
AAAAAATGGACGGCACCGAGGAGCTGCTGGTAAAGCTTAACAGAGAAGATCTGTTGCGCAAACAGCGCACTTTCGACAAT
GGAAGCATCCCCCACCAGATTCACCTGGGCGAACTGCACGCTATCCTCAGGCGGCAAGAGGATTTCTACCCCTTTTTGAA
AGATAACAGGGAAAAGATTGAGAAAATCCTCACATTTCGGATACCCTACTATGTAGGCCCCCTCGCCCGGGGAAATTCCA
GATTCGCGTGGATGACTCGCAAATCAGAAGAGACCATCACTCCCTGGAACTTCGAGGAAGTCGTGGATAAGGGGGCCTCT
GCCCAGTCCTTCATCGAAAGGATGACTAACTTTGATAAAAATCTGCCTAACGAAAAGGTGCTTCCTAAACACTCTCTGCT
GTACGAGTACTTCACAGTTTATAACGAGCTCACCAAGGTCAAATACGTCACAGAAGGGATGAGAAAGCCAGCATTCCTGT
CTGGAGAGCAGAAGAAAGCTATCGTGGACCTCCTCTTCAAGACGAACCGGAAAGTTACCGTGAAACAGCTCAAAGAAGAC
TATTTCAAAAAGATTGAATGTTTCGACTCTGTTGAAATCAGCGGAGTGGAGGATCGCTTCAACGCATCCCTGGGAACGTA
TCACGATCTCCTGAAAATCATTAAAGACAAGGACTTCCTGGACAATGAGGAGAACGAGGACATTCTTGAGGACATTGTCC
TCACCCTTACGTTGTTTGAAGATAGGGAGATGATTGAAGAACGCTTGAAAACTTACGCTCATCTCTTCGACGACAAAGTC
ATGAAACAGCTCAAGAGGCGCCGATATACAGGATGGGGGCGGCTGTCAAGAAAACTGATCAATGGGATCCGAGACAAGCA
GAGTGGAAAGACAATCCTGGATTTTCTTAAGTCCGATGGATTTGCCAACCGGAACTTCATGCAGTTGATCCATGATGACT
CTCTCACCTTTAAGGAGGACATCCAGAAAGCACAAGTTTCTGGCCAGGGGGACAGTCTTCACGAGCACATCGCTAATCTT
GCAGGTAGCCCAGCTATCAAAAAGGGAATACTGCAGACCGTTAAGGTCGTGGATGAACTCGTCAAAGTAATGGGAAGGCA
TAAGCCCGAGAATATCGTTATCGAGATGGCCCGAGAGAACCAAACTACCCAGAAGGGACAGAAGAACAGTAGGGAAAGGA
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TGAAGAGGATTGAAGAGGGTATAAAAGAACTGGGGTCCCAAATCCTTAAGGAACACCCAGTTGAAAACACCCAGCTTCAG
AATGAGAAGCTCTACCTGTACTACCTGCAGAACGGCAGGGACATGTACGTGGATCAGGAACTGGACATCAATCGGCTCTC
CGACTACGACGTGGATCATATCGTGCCCCAGTCTTTTCTCAAAGATGATTCTATTGATAATAAAGTGTTGACAAGATCCG
ATAAAAATAGAGGGAAGAGTGATAACGTCCCCTCAGAAGAAGTTGTCAAGAAAATGAAAAATTATTGGCGGCAGCTGCTG
AACGCCAAACTGATCACACAACGGAAGTTCGATAATCTGACTAAGGCTGAACGAGGTGGCCTGTCTGAGTTGGATAAAGC
CGGCTTCATCAAAAGGCAGCTTGTTGAGACACGCCAGATCACCAAGCACGTGGCCCAAATTCTCGATTCACGCATGAACA
CCAAGTACGATGAAAATGACAAACTGATTCGAGAGGTGAAAGTTATTACTCTGAAGTCTAAGCTGGTCTCAGATTTCAGA
AAGGACTTTCAGTTTTATAAGGTGAGAGAGATCAACAATTACCACCATGCGCATGATGCCTACCTGAATGCAGTGGTAGG
CACTGCACTTATCAAAAAATATCCCAAGCTTGAATCTGAATTTGTTTACGGAGACTATAAAGTGTACGATGTTAGGAAAA
TGATCGCAAAGTCTGAGCAGGAAATAGGCAAGGCCACCGCTAAGTACTTCTTTTACAGCAATATTATGAATTTTTTCAAG
ACCGAGATTACACTGGCCAATGGAGAGATTCGGAAGCGACCACTTATCGAAACAAACGGAGAAACAGGAGAAATCGTGTG
GGACAAGGGTAGGGATTTCGCGACAGTCCGGAAGGTCCTGTCCATGCCGCAGGTGAACATCGTTAAAAAGACCGAAGTAC
AGACCGGAGGCTTCTCCAAGGAAAGTATCCTCCCGAAAAGGAACAGCGACAAGCTGATCGCACGCAAAAAAGATTGGGAC
CCCAAGAAATACGGCGGATTCGATTCTCCTACAGTCGCTTACAGTGTACTGGTTGTGGCCAAAGTGGAGAAAGGGAAGTC
TAAAAAACTCAAAAGCGTCAAGGAACTGCTGGGCATCACAATCATGGAGCGATCAAGCTTCGAAAAAAACCCCATCGACT
TTCTCGAGGCGAAAGGATATAAAGAGGTCAAAAAAGACCTCATCATTAAGCTTCCCAAGTACTCTCTCTTTGAGCTTGAA
AACGGCCGGAAACGAATGCTCGCTAGTGCGGGCGAGCTGCAGAAAGGTAACGAGCTGGCACTGCCCTCTAAATACGTTAA
TTTCTTGTATCTGGCCAGCCACTATGAAAAGCTCAAAGGGTCTCCCGAAGATAATGAGCAGAAGCAGCTGTTCGTGGAAC
AACACAAACACTACCTTGATGAGATCATCGAGCAAATAAGCGAATTCTCCAAAAGAGTGATCCTCGCCGACGCTAACCTC
GATAAGGTGCTTTCTGCTTACAATAAGCACAGGGATAAGCCCATCAGGGAGCAGGCAGAAAACATTATCCACTTGTTTAC
TCTGACCAACTTGGGCGCGCCTGCAGCCTTCAAGTACTTCGACACCACCATAGACAGAAAGCGGTACACCTCTACAAAGG
AGGTCCTGGACGCCACACTGATTCATCAGTCAATTACGGGGCTCTATGAAACAAGAATCGACCTCTCTCAGCTCGGTGGA
GACAGCAGGGCTGACCCCAAGAAGAAGAGGAAGGTGGCATGCATCCAGGCTAGCGTGAATTTACTTTAAATCTTGCATTT
AAATAAATTTTCTTTTTATAGCTTTATGACTTAGTTTCAATTTATATACTATTTTAATGACATTTTCGATTCATTGATTG
AAAGCTTTGTGTTTTTTCTTGATGCGCTATTGCATTGTTCTTGTCTTTTTCGCCACATGTAATATCTGTAGTAGATACCT
GATACATTGTGGATGCTGAGTGAAATTTTAGTTAATAATGGAGGCGCTCTTAATAATTTTGGGGATATTGGCTTTTTTTT
TTAAAGTTTACAAATGAATTTTTTCCGCCAGGATGCGGCCGCTCTAGACTAGTCCTAGGGGATCCGTCACCCGGCCAGCG
GAATTCAGGGATGATCTTGAGAAGTTCTTAGAGTCTTACGAGGGAACAGAAGATTTGGAACCAGCCAAAGCTGCTATAGC
GGAAGCAGATATTTTGCTAAGTAAATGATTAAATAATTAAATATGTGGAAATACATTAATCTTTTTATATTTTTGCAGTT
CGTTGTCGCTATAATTTATAGTCATCTCGTTAGTTCAAACAAGACTTCTTGAAGTGAAAACCAACTTTCAGTCTTCAAAC
TAAAAATGAAAATCAGTGGAAGAAGGTAAACGACTTCATGTTATATATGAATTGAATAGTAATGGAAATAACCAAAAACA
GCTCAACAGAAAACAAACAAAATACGTTAAGACCTGAACTCCTAGCAGAACCATAACTGCCAAATATTTATTATCTGTGG
AGATCTTATATTCTAAAACCAAAAAAAATATAACTTAAAAGTTAAAAAGAAGATGTTCTAACTGAGGTTCGAACTCAGGA
CCTTTGCCGTGTGAAGGCAACGTGATAGCCACTACACTATTAGAACTACCTTATGGGAAAAAGAAAAATAGAGTACAACT
AGAATGGTAAGATCTGTGACCTTTTCTAAACACTTAATTCCATATAGACAGTTCCCACCCACCATAAGGTCACAATTATA
ATGTCTTTAGAAGACCACTGTCGTTCATCATCTTCCTAAGCCCTCTCTCTAAAGCGGCATATTTCCGTAATTTGTTCTTC
53 
 
TTTGCACAGGCACGTGAGATGACTCCGATTATTCCCACATGCATATTTAGCCTCTCTAGGGGCTCGAGCTATAGCAAGTT
CAAGGAAAGAAAACTATTATGATCTGGTCACGTGTATAAAATTTATTAATTTTAAAACTATATAATTTATTATTTTTTTA
TTTTAAAGTTTAAAGTAATTTTAATAGTATTCTATATTTTAAATAAACATACTTTAAAATTTTATTTAATAATTTATTAT
TTTTAAATACAATGTTTTTATTTAAAACAAAATTATAAGTTAAAAAGTTGTTCCGAAAGTAAAATATATTTTATAGGACG
TCGACATGGAGGCCCAGAATACCCTCCTTGACAGTCTTGACGTGCGCAGCTCAGGGGCATGATGTGACTGTCGCCCGTAC
ATTTAGCCCATACATCCCCATGTATAATCATTTGCATCCATACATTTTGATGGCCGCACGGCGCGAAGCAAAAATTACGG
CTCCTCGCTGCAGACCTGCGAGCAGGGAAACGCTCCCCTCACAGACGCGTTGAATTGTCCCCACGCCGCGCCCCTGTAGA
GAAATATAAAAGGTTAGGATTTGCCACTGAGGTTCTTCTTTCATATACTTCCTTTTAAAATCTTGCTAGGATACAGTTCT
CACATCACATCCGAACATAAACAACCATGGGTAAGGAAAAGACTCACGTTTCGAGGCCGCGATTAAATTCCAACATGGAT
GCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCC
CGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACT
GGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCG
ATCCCCGGCAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTT
CCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAAT
CACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAA
GAAATGCATAAGCTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGA
CGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGA
ACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAA
TTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAATCAGTACTGACAATAAAAAGATTCTTGTTTTCAAGAACTTGTCA
TTTGTATAGTTTTTTTATATTGTAGTTGTTCTATTTTAATCAAATGTTAGCGTGATTTATATTTTTTTTCGCCTCGACAT
CATCTGCCCAGATGCGAAGTTAAGTGCGCAGAAAGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTGC
CTAGGCCGGCCATAGGGATAACAGGGTAATGTTAACCGGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAA
TCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGC
GCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGC
TCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGA
CCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTG
GTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGA
AGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACA
AACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTT
TGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGG
ATCTTCACCTAGATCCTTTTAAATT 
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AAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCA
CCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGAACCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGC
CAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCT
AGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTT
TGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTA
GCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAAT
TCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTAT
GCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCA
TTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCA
CCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAA
GGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATT
GTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGTTAATTAATTGAGATAAGC
ACACTGCACCCATACCTTCCTTAAAAACGTAGCTTCCAGTTTTTGGTGGTTCCGGCTTCCTTCCCGATTCCGCCCGCTAA
ACGCATATTTTTGTTGCCTGGTGGCATTTGCAAAATGCATAACCTATGCATTTAAAAGATTATGTATGCTCTTCTGACTT
TTCGTGTGATGAGGCTCGTGGAAAAAATGAATAATTTATGAATTTGAGAACAATTTTGTGTTGTTACGGTATTTTACTAT
GGAATAATCAATCAATTGAGGATTTTATGCAAATATCGTTTGAATATTTTTCCGACCCTTTGAGTACTTTTCTTCATAAT
TGCATAATATTGTCCGCTGCCCCTTTTTCTGTTAGACGGTGTCTTGATCTACTTGCTATCGTTCAACACCACCTTATTTT
CTAACTATTTTTTTTTTAGCTCATTTGAATCAGCTTATGGTGATGGCACATTTTTGCATAAACCTAGCTGTCCTCGTTGA
ACATAGGAAAAAAAAATATATAAACAAGGCTCTTTCACTCTCCTTGCAATCAGATTTGGGTTTGTTCCCTTTATTTTCAT
ATTTCTTGTCATATTCCTTTCTCAATTATTATTTTCTACTCATAACCTCACGCAAAATAACACAGTCAAATCAATCAAAG
CTAGCGAAATGGCACCGAAGAAGAAGCGTAAAGTCGGAATCCACGGAGTTCCTGCGGCAATGGACAAGAAGTACTCCATT
GGGCTCGCTATCGGCACAAACAGCGTCGGTTGGGCCGTCATTACGGACGAGTACAAGGTGCCGAGCAAAAAATTCAAAGT
TCTGGGCAATACCGATCGCCACAGCATAAAGAAGAACCTCATTGGCGCCCTCCTGTTCGACTCCGGGGAGACGGCCGAAG
CCACGCGGCTCAAAAGAACAGCACGGCGCAGATATACCCGCAGAAAGAATCGGATCTGCTACCTGCAGGAGATCTTTAGT
AATGAGATGGCTAAGGTGGATGACTCTTTCTTCCATAGGCTGGAGGAGTCCTTTTTGGTGGAGGAGGATAAAAAGCACGA
GCGCCACCCAATCTTTGGCAATATCGTGGACGAGGTGGCGTACCATGAAAAGTACCCAACCATATATCATCTGAGGAAGA
AGCTTGTAGACAGTACTGATAAGGCTGACTTGCGGTTGATCTATCTCGCGCTGGCGCATATGATCAAATTTCGGGGACAC
TTCCTCATCGAGGGGGACCTGAACCCAGACAACAGCGATGTCGACAAACTCTTTATCCAACTGGTTCAGACTTACAATCA
GCTTTTCGAAGAGAACCCGATCAACGCATCCGGAGTTGACGCCAAAGCAATCCTGAGCGCTAGGCTGTCCAAATCCCGGC
GGCTCGAAAACCTCATCGCACAGCTCCCTGGGGAGAAGAAGAACGGCCTGTTTGGTAATCTTATCGCCCTGTCACTCGGG
CTGACCCCCAACTTTAAATCTAACTTCGACCTGGCCGAAGATGCCAAGCTTCAACTGAGCAAAGACACCTACGATGATGA
TCTCGACAATCTGCTGGCCCAGATCGGCGACCAGTACGCAGACCTTTTTTTGGCGGCAAAGAACCTGTCAGACGCCATTC
TGCTGAGTGATATTCTGCGAGTGAACACGGAGATCACCAAAGCTCCGCTGAGCGCTAGTATGATCAAGCGCTATGATGAG
CACCACCAAGACTTGACTTTGCTGAAGGCCCTTGTCAGACAGCAACTGCCTGAGAAGTACAAGGAAATTTTCTTCGATCA
GTCTAAAAATGGCTACGCCGGATACATTGACGGCGGAGCAAGCCAGGAGGAATTTTACAAATTTATTAAGCCCATCTTGG
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AAAAAATGGACGGCACCGAGGAGCTGCTGGTAAAGCTTAACAGAGAAGATCTGTTGCGCAAACAGCGCACTTTCGACAAT
GGAAGCATCCCCCACCAGATTCACCTGGGCGAACTGCACGCTATCCTCAGGCGGCAAGAGGATTTCTACCCCTTTTTGAA
AGATAACAGGGAAAAGATTGAGAAAATCCTCACATTTCGGATACCCTACTATGTAGGCCCCCTCGCCCGGGGAAATTCCA
GATTCGCGTGGATGACTCGCAAATCAGAAGAGACCATCACTCCCTGGAACTTCGAGGAAGTCGTGGATAAGGGGGCCTCT
GCCCAGTCCTTCATCGAAAGGATGACTAACTTTGATAAAAATCTGCCTAACGAAAAGGTGCTTCCTAAACACTCTCTGCT
GTACGAGTACTTCACAGTTTATAACGAGCTCACCAAGGTCAAATACGTCACAGAAGGGATGAGAAAGCCAGCATTCCTGT
CTGGAGAGCAGAAGAAAGCTATCGTGGACCTCCTCTTCAAGACGAACCGGAAAGTTACCGTGAAACAGCTCAAAGAAGAC
TATTTCAAAAAGATTGAATGTTTCGACTCTGTTGAAATCAGCGGAGTGGAGGATCGCTTCAACGCATCCCTGGGAACGTA
TCACGATCTCCTGAAAATCATTAAAGACAAGGACTTCCTGGACAATGAGGAGAACGAGGACATTCTTGAGGACATTGTCC
TCACCCTTACGTTGTTTGAAGATAGGGAGATGATTGAAGAACGCTTGAAAACTTACGCTCATCTCTTCGACGACAAAGTC
ATGAAACAGCTCAAGAGGCGCCGATATACAGGATGGGGGCGGCTGTCAAGAAAACTGATCAATGGGATCCGAGACAAGCA
GAGTGGAAAGACAATCCTGGATTTTCTTAAGTCCGATGGATTTGCCAACCGGAACTTCATGCAGTTGATCCATGATGACT
CTCTCACCTTTAAGGAGGACATCCAGAAAGCACAAGTTTCTGGCCAGGGGGACAGTCTTCACGAGCACATCGCTAATCTT
GCAGGTAGCCCAGCTATCAAAAAGGGAATACTGCAGACCGTTAAGGTCGTGGATGAACTCGTCAAAGTAATGGGAAGGCA
TAAGCCCGAGAATATCGTTATCGAGATGGCCCGAGAGAACCAAACTACCCAGAAGGGACAGAAGAACAGTAGGGAAAGGA
TGAAGAGGATTGAAGAGGGTATAAAAGAACTGGGGTCCCAAATCCTTAAGGAACACCCAGTTGAAAACACCCAGCTTCAG
AATGAGAAGCTCTACCTGTACTACCTGCAGAACGGCAGGGACATGTACGTGGATCAGGAACTGGACATCAATCGGCTCTC
CGACTACGACGTGGATCATATCGTGCCCCAGTCTTTTCTCAAAGATGATTCTATTGATAATAAAGTGTTGACAAGATCCG
ATAAAAATAGAGGGAAGAGTGATAACGTCCCCTCAGAAGAAGTTGTCAAGAAAATGAAAAATTATTGGCGGCAGCTGCTG
AACGCCAAACTGATCACACAACGGAAGTTCGATAATCTGACTAAGGCTGAACGAGGTGGCCTGTCTGAGTTGGATAAAGC
CGGCTTCATCAAAAGGCAGCTTGTTGAGACACGCCAGATCACCAAGCACGTGGCCCAAATTCTCGATTCACGCATGAACA
CCAAGTACGATGAAAATGACAAACTGATTCGAGAGGTGAAAGTTATTACTCTGAAGTCTAAGCTGGTCTCAGATTTCAGA
AAGGACTTTCAGTTTTATAAGGTGAGAGAGATCAACAATTACCACCATGCGCATGATGCCTACCTGAATGCAGTGGTAGG
CACTGCACTTATCAAAAAATATCCCAAGCTTGAATCTGAATTTGTTTACGGAGACTATAAAGTGTACGATGTTAGGAAAA
TGATCGCAAAGTCTGAGCAGGAAATAGGCAAGGCCACCGCTAAGTACTTCTTTTACAGCAATATTATGAATTTTTTCAAG
ACCGAGATTACACTGGCCAATGGAGAGATTCGGAAGCGACCACTTATCGAAACAAACGGAGAAACAGGAGAAATCGTGTG
GGACAAGGGTAGGGATTTCGCGACAGTCCGGAAGGTCCTGTCCATGCCGCAGGTGAACATCGTTAAAAAGACCGAAGTAC
AGACCGGAGGCTTCTCCAAGGAAAGTATCCTCCCGAAAAGGAACAGCGACAAGCTGATCGCACGCAAAAAAGATTGGGAC
CCCAAGAAATACGGCGGATTCGATTCTCCTACAGTCGCTTACAGTGTACTGGTTGTGGCCAAAGTGGAGAAAGGGAAGTC
TAAAAAACTCAAAAGCGTCAAGGAACTGCTGGGCATCACAATCATGGAGCGATCAAGCTTCGAAAAAAACCCCATCGACT
TTCTCGAGGCGAAAGGATATAAAGAGGTCAAAAAAGACCTCATCATTAAGCTTCCCAAGTACTCTCTCTTTGAGCTTGAA
AACGGCCGGAAACGAATGCTCGCTAGTGCGGGCGAGCTGCAGAAAGGTAACGAGCTGGCACTGCCCTCTAAATACGTTAA
TTTCTTGTATCTGGCCAGCCACTATGAAAAGCTCAAAGGGTCTCCCGAAGATAATGAGCAGAAGCAGCTGTTCGTGGAAC
AACACAAACACTACCTTGATGAGATCATCGAGCAAATAAGCGAATTCTCCAAAAGAGTGATCCTCGCCGACGCTAACCTC
GATAAGGTGCTTTCTGCTTACAATAAGCACAGGGATAAGCCCATCAGGGAGCAGGCAGAAAACATTATCCACTTGTTTAC
TCTGACCAACTTGGGCGCGCCTGCAGCCTTCAAGTACTTCGACACCACCATAGACAGAAAGCGGTACACCTCTACAAAGG
56 
 
AGGTCCTGGACGCCACACTGATTCATCAGTCAATTACGGGGCTCTATGAAACAAGAATCGACCTCTCTCAGCTCGGTGGA
GACAGCAGGGCTGACCCCAAGAAGAAGAGGAAGGTGGGTGGAGGAGGTACCGGCGGTGGAGGCTCAGCAGAATACGTACG
AGCTCTGTTTGACTTCAATGGGAATGACGAGGAGGATCTCCCCTTTAAGAAGGGCGATATTCTCCGCATCAGAGATAAGC
CCGAAGAACAATGGTGGAATGCCGAGGATAGCGAAGGGAAAAGGGGCATGATTCTGGTGCCATATGTGGAGAAATATTCC
GGTGACTACAAAGACCATGATGGGGATTACAAAGACCACGACATCGACTACAAAGACGACGACGATAAATCAGGGATGAC
AGACGCCGAGTACGTGCGCATTCATGAGAAACTGGATATTTACACCTTCAAGAAGCAGTTCTTCAACAACAAGAAATCTG
TGTCACACCGCTGCTACGTGCTGTTTGAGTTGAAGCGAAGGGGCGAAAGAAGGGCTTGCTTTTGGGGCTATGCCGTCAAC
AAGCCCCAAAGTGGCACCGAGAGAGGAATACACGCTGAGATATTCAGTATCCGAAAGGTGGAAGAGTATCTTCGGGATAA
TCCTGGGCAGTTTACGATCAACTGGTATTCCAGCTGGAGTCCTTGCGCTGATTGTGCCGAGAAAATTCTGGAATGGTATA
ATCAGGAACTTCGGGGAAACGGGCACACATTGAAAATCTGGGCCTGCAAGCTGTACTACGAGAAGAATGCCCGGAACCAG
ATAGGACTCTGGAATCTGAGGGACAATGGTGTAGGCCTGAACGTGATGGTTTCCGAGCACTATCAGTGTTGTCGGAAGAT
TTTCATCCAAAGCTCTCATAACCAGCTCAATGAAAACCGCTGGTTGGAGAAAACACTGAAACGTGCGGAGAAGCGGAGAT
CCGAGCTGAGCATCATGATCCAGGTCAAGATTCTGCATACCACTAAGTCTCCAGCCGTTGGTCCCAAGAAGAAAAGAAAA
GTCGCATGCATCCAGGCTAGCGTGAATTTACTTTAAATCTTGCATTTAAATAAATTTTCTTTTTATAGCTTTATGACTTA
GTTTCAATTTATATACTATTTTAATGACATTTTCGATTCATTGATTGAAAGCTTTGTGTTTTTTCTTGATGCGCTATTGC
ATTGTTCTTGTCTTTTTCGCCACATGTAATATCTGTAGTAGATACCTGATACATTGTGGATGCTGAGTGAAATTTTAGTT
AATAATGGAGGCGCTCTTAATAATTTTGGGGATATTGGCTTTTTTTTTTAAAGTTTACAAATGAATTTTTTCCGCCAGGA
TGCGGCCGCTCTAGACTAGTCCTAGGGGATCCGTCACCCGGCCAGCGGAATTCAGGGATGATCTTGAGAAGTTCTTAGAG
TCTTACGAGGGAACAGAAGATTTGGAACCAGCCAAAGCTGCTATAGCGGAAGCAGATATTTTGCTAAGTAAATGATTAAA
TAATTAAATATGTGGAAATACATTAATCTTTTTATATTTTTGCAGTTCGTTGTCGCTATAATTTATAGTCATCTCGTTAG
TTCAAACAAGACTTCTTGAAGTGAAAACCAACTTTCAGTCTTCAAACTAAAAATGAAAATCAGTGGAAGAAGGTAAACGA
CTTCATGTTATATATGAATTGAATAGTAATGGAAATAACCAAAAACAGCTCAACAGAAAACAAACAAAATACGTTAAGAC
CTGAACTCCTAGCAGAACCATAACTGCCAAATATTTATTATCTGTGGAGATCTTATATTCTAAAACCAAAAAAAATATAA
CTTAAAAGTTAAAAAGAAGATGTTCTAACTGAGGTTCGAACTCAGGACCTTTGCCGTGTGAAGGCAACGTGATAGCCACT
ACACTATTAGAACTACCTTATGGGAAAAAGAAAAATAGAGTACAACTAGAATGGTAAGATCTGTGACCTTTTCTAAACAC
TTAATTCCATATAGACAGTTCCCACCCACCATAAGGTCACAATTATAATGTCTTTAGAAGACCACTGTCGTTCATCATCT
TCCTAAGCCCTCTCTCTAAAGCGGCATATTTCCGTAATTTGTTCTTCTTTGCACAGGCACGTGAGATGACTCCGATTATT
CCCACATGCATATTTAGCCTCTCTAGGGGCTCGAGCTATAGCAAGTTCAAGGAAAGAAAACTATTATGATCTGGTCACGT
GTATAAAATTTATTAATTTTAAAACTATATAATTTATTATTTTTTTATTTTAAAGTTTAAAGTAATTTTAATAGTATTCT
ATATTTTAAATAAACATACTTTAAAATTTTATTTAATAATTTATTATTTTTAAATACAATGTTTTTATTTAAAACAAAAT
TATAAGTTAAAAAGTTGTTCCGAAAGTAAAATATATTTTATAGGACGTCGACATGGAGGCCCAGAATACCCTCCTTGACA
GTCTTGACGTGCGCAGCTCAGGGGCATGATGTGACTGTCGCCCGTACATTTAGCCCATACATCCCCATGTATAATCATTT
GCATCCATACATTTTGATGGCCGCACGGCGCGAAGCAAAAATTACGGCTCCTCGCTGCAGACCTGCGAGCAGGGAAACGC
TCCCCTCACAGACGCGTTGAATTGTCCCCACGCCGCGCCCCTGTAGAGAAATATAAAAGGTTAGGATTTGCCACTGAGGT
TCTTCTTTCATATACTTCCTTTTAAAATCTTGCTAGGATACAGTTCTCACATCACATCCGAACATAAACAACCATGGGTA
AGGAAAAGACTCACGTTTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGAT
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AATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAA
AGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCA
AGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGCAAAACAGCATTCCAGGTATTAGAA
GAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAA
TTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTG
ATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCACCGGAT
TCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGG
ACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGA
AACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTC
TAATCAGTACTGACAATAAAAAGATTCTTGTTTTCAAGAACTTGTCATTTGTATAGTTTTTTTATATTGTAGTTGTTCTA
TTTTAATCAAATGTTAGCGTGATTTATATTTTTTTTCGCCTCGACATCATCTGCCCAGATGCGAAGTTAAGTGCGCAGAA
AGTAATATCATGCGTCAATCGTATGTGAATGCTGGTCGCTATACTGCCTAGGCCGGCCATAGGGATAACAGGGTAATGTT
AACCGGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGAC
AGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGAT
ACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTC
GTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGA
GTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCG
GTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAG
CCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTG
CAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGA
ACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATT 
Figure 2 Plasmid nCas9-CDA_Base sequences. 
Light green: ScPPDC1, Red: nCas9 protein, Gray: ScTTDH3, Cyan: KmARS7, Green: 
KmCEN-D, Yellow: kanMX 
 
 
Construction of target sequence-containing plasmids 
To generate the sgRNA expression casettes, the K. marxianus SNR52 promoter 
(KmPSNR52) (531 bp; identified by alignment with the S. cerevisiae gene) was amplified 
by PCR using the combination of the forward primer (P_Km01-013) and each reverse 
primer (5’-CTAGCTCTAAAAC- reverse complement of target 
sequence-GATTCGAACTGCGGACGTTG-3’). The sgRNA scaffold and the SUP4 
terminator were amplified by PCR from plasmid 
pRS426-SNR52p-gRNA.CAN1.Y-SUP4t (Dicarlo et al. 2013) using the primers 
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P_Km01-014 and P_Km01-015 (Table 2). The two fragments were fused by overlap 
extension PCR using the primers P_Km01-013 and P_Km01-015 to yield each 
target-containing sgRNA cassette (Figure 3). Each cassette was digested with restriction 
enzymes NotI and NheI and ligated into NotI-, SpeI-digested nCas9-CDA_Base or 
Cas9_Base plasmid. 
 
Transformation 
K. marxianus cells were transformed by the lithium acetate method (Gietz et al. 
1992). After transformation, cells were plated on YPD containing appropriate selection 
reagents (100 g/mL G418 and/or 50 g/mL zeocin) and grown for one day. For the 
5-FOA test, cells were streaked onto YPD containing 3 mg/mL 5-FOA, incubated 
overnight, and assessed for growth. Colony PCR was performed to check fragment size 
and to obtain DNA for Sanger sequencing using a 3130xL Genetic Analyzer (Applied 
Biosystems, CA, USA). 
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Table 2 Primers used in this study 
Primer name Sequence (5'-3') Purpose 
Universal primers for sgRNA cassette construction 
 
P_Km01_013(pKmSNR52_Fw) aagctagctctagaTGCCGCAAATAGGGCAGG amplification of PKmSNR52 region 
P_Km01_014(tracerRNA_Fw) GTTTTAGAGCTAGAAATAGCAAG amplification of tracrRNA_Tsup4 fragment 
P_Km01_015(tracerRNA_Rv) 
cctgaattcGCGGCCGCatactagtCATAAAAAACAAAAAAA
GCACCACC 
amplification of tracrRNA_Tsup4 fragment 
   
Target-specific primers  
  
P_Km01_016(single1(NEJ1)_Fw) 
CTAGCTCTAAAACCTTATTATCAGTATTTTGTAGATT
CGAACTGCGGACGTTG 
amplification of target NEJ1 
P_Km01_017(single2(DNL4)_Fw) 
CTAGCTCTAAAACTCTCCAGAGTTTAAATGGTTGAT
TCGAACTGCGGACGTTG 
amplification of target Dnl4 
P_Km01_018(deletion1(Ura3)_Fw) 
CTAGCTCTAAAACCCTTTGATTAGTTTATGGGCGATT
CGAACTGCGGACGTTG 
amplification of target Ura3_Fw 
P_Km01_019(deletion2(Ura3)_Rv) 
CTAGCTCTAAAACAGAACAAGCAGAGGTTCGAGGA
TTCGAACTGCGGACGTTG 
amplification of target Ura3_Rv 
P_Km01_059(deletion2(Sed1)_Fw) 
CTAGCTCTAAAACCTGGAATAGAACTGGATGTGGAT
TCGAACTGCGGACGTTG 
amplification of target Sed1-2 
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Primer pairs for insert donor DNA  
  
P_Km01_039(Ura3(5)_Fw) ACCTTAAGTAGTCAAACAAATTGTG 
amplification of GFP and bleomycin 
expression donor DNA containing length 
of 1000 bp Ura3 homologous sequence 
(donor DNA-I) 
P_Km01_046(Ura3(3)_Rv) CAGAGAGTCTGCAACACCGA 
Ura3_up_100F TGAATCTGAGCTCATCACCAAC amplification of GFP and bleomycin 
expression donor DNA containing length 
of 122/109 bp Ura3 homologous sequence 
(donor DNA-II) 
Ura3_down100_R GTATACAATGTGCGCAATGCC 
P_Km01_052(Ble_GFP_50bp_Rv) TGGAACAGCAAGAGGAAGTATC amplification of GFP expression donor 
DNA containing length of 50 bp Ura3 
homologous sequence (donor DNA-III) 
P_Km01_053(GFP_50bp_Fw) 
GATCAACTTGTAACTTCTGATCCGAGTACACTCGAA
CCTCTGCTTGTTCTgatcccttgtacagctcgtc 
P_Km01_060(GFP_Sed1_Fw) 
TATTCGTGGTACCAGTTTTATTTGCATCATCTGCATT
TGCTGCTTTCTCTatggtgagcaagggcga amplification of GFP codin region donor 
DNA containing length of 50 bp Sed1 
homologous sequence (donor DNA-IV) P_Km01_061(GFP_Sed1_Rv) 
gaaGATGGGGCAACTGAGGTCACtACTGGAATAGAA
CTGGATGTGTCGTTacccttgtacagctcgtcca 
P_Km01_052(Ble_GFP_50bp_Rv) TGGAACAGCAAGAGGAAGTATC amplification of PPDC1 region donor DNA 
containing length of 50 bp homologous 
sequence (donor DNA-V) 
P_Km01_064(pPDC1_Fw) atgggcaccaccccggtgaa 
P_Km01_065(EGFP_Rv) GCTAGCatggtgagcaaggg amplification of GFP coding region donor 
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P_Km01_066(EGFP_Fw) 
AACTATACAAATGACAAGTTCTTGAAAACAAGAAT
CTTTTTATTGTCAGTgatcccttgtacagctcgtc 
DNA containing length of 50 bp 
homologous sequence (donor DNA-VI) 
P_Km01_051(Ble_GFP_50bp_Fw) GATCAACTTGTAACTTCTGATCCG amplification of TTEF1 region donor DNA 
containing length of 50 bp homologous 
sequence (donor DNA-VII) 
P_Km01_067(TEF1t_Rv) ACTGACAATAAAAAGATTCTTGT 
Red indicates each target sequence. 
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AAGCTAGCTCTAGATGCCGCAAATAGGGCAGGCGATATACAAGGCGGTATACAGGGCGGTATACAAGGCGTATGCCAGAC
GGTATGCCTGGAGGCATTGTCAGGAGGCATTGTCAGGAGGCATTGCCGGGCGAAATCGCCAGCTTGAGTATGGCCCCAGA
GGGAAGAAAAAACAGTTACCCAGGTGTGTGCCCCTGTATTACCCTGACTTTGAAATGTACGCGAAGTACACTTCGTGCAG
GGTGATGATGCTCGTATCAGGTGGACTTGGCGGACACGGTACGGTACGGTCCCCTTTTTTTATTTTTTCTTTTGGGAATG
AGAAGGCCACGTGACGTTACCCTGGCCCTGTGTTTCCCCCCTCGCATCTTGTACTGCCTTAGGACCCCTCGTAGTGTAGC
GGTCCGGGCCCCCAGATTGCGATGTGTTTCGAGAAAAACAACAAAAAAAATAAGTTGAAAAGCGCGGATCAGGCGGTCCG
CCCGGAGTGCGCGCGCTGTATTCTCGCCTGACAGGGCGGGATTCGCAACGTCCGCAGTTCGAATCNNNNNNNNNNNNNNN
NNNNNGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTG
GTGCTTTTTTTGTTTTTTATGACTAGTATGCGGCCGCGAATTCAGG 
Figure 3 Sequence of target-containing sgRNA cassette. 
“N” indicates target specific sequence. This sequence indicates as follows: Purple: 
KmPSNR52, Gray: sgRNA, Green: Sup4 terminator. 
 
 
Donor DNA templates 
Each donor DNA template was constructed by PCR and cloned into the plasmid 
TOPO/F7 using the Zero Blunt
®
 TOPO
®
 PCR Cloning Kit (Invitrogen, CA, USA) 
(Figure 4). Each cloned donor DNA was either excised by restriction enzymes or 
amplified by PCR using the respective primer pair (Table 2), and the resulting fragment 
was purified by agarose gel electrophoresis before use in transformation. 
 
AGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGG
AAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCC
GGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGCCAAGCTCA
GAATTAACCCTCACTAAAGGGACTAGTCCTGCAGGTTTAAACGAATTCGCCCTTCAGAGAGTCTGCAACACCGATTTATC
GGTTTGCAGGTAACACAATACCGATTACTTGGTGTCTGAGGAGATCTCAATTCTCTCTTTTTCCTTCAACTTTTATTTTC
TTGGTATGCTTCTTGTGCATTCGCCTATTAATTTATATTAGCGATTCTTATGACATCGGCCATCACTGAGTATAGTGAGT
AGTAGTGGTTGATATTTGAAATCTATTATAGATAAGTTCCTTTACATATCGTGCAGCACTTGTTTATGTGAACTATTAGT
AGCTATATTGGCTATATACAGAGAGAAAGCTATAACTATTTATATCATAACTGTTTGTATAACTTAACGACCCATGCTTT
GGTTCAAAGCAGCGTTTTGCTCTTGGAAACGTTGTCCAACACGTTCACTATGTTTCAAGAACTTTTCTGAGCATTTCATT
ATGCAGCTTTGCTCCTTGGAAGTTAGCTTAGCAGAGGTAAAGTCGTTGACACAGTCACTGAAACATCTTTCGACCAAGTT
GGAGTATAGACGCATGAAGTCCTTCATTTGCTTTTGTTCCACAATTCTTTGGAACTCTTGTTGTTCCTTACCATTTAGTT
GATCCATTTTTAACTGTGTATTTGATTTTTTTGTTCTAGCAATCGACGGTCCAAGACTCAATAAAAATTGACTCTTGTAT
CTTTCTTCACACTAGTAGTAAAGCAGAAAGTCTAGCAGAAATGTGTATCTTTTATAACGGTCAATGGTCTAAGAAGCAAG
GTTTGGTTCTTCGCACTTGTATTAAACTCTTTTTCTTTGGTTGTGAAATTTCACATAATGTACTTCACCAAAAAACAAAA
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AAAAAAAAAAAAAAAAAAATTTTCGGTGCAAAAAACAGCTTCTAGCACGTGACTAAACTTGTAGCGTATACAATGTGCGC
AATGCCATTACACTCTAACATCTCTGTATAGTTTATATATAAACGATCAACTTGTAACTTCTGATCCGAGTACACTCGAA
CCTCTGCTTGTTCTCAGTATAGCGACCAGCATTCACATACGATTGACGCATGATATTACTTTCTGCGCACTTAACTTCGC
ATCTGGGCAGATGATGTCGAGGCGAAAAAAAATATAAATCACGCTAACATTTGATTAAAATAGAACAACTACAATATAAA
AAAACTATACAAATGACAAGTTCTTGAAAACAAGAATCTTTTTATTGTCAGTACTGATCATGAGATGCCTGCAAGCAATT
CGTTCTGTATCAGGCGCAGGAGCGTCCCGTCCGGGTCGACCAAAGCGGCCATCGTGCCTCCCCACTCCTGCAGTTCGGGG
GCATGGATGCGCGGATAGCCGCTGCTGGTTTCCTGGATGCCGACGGATTTGCACTGCCGGTAGAACTCCGCGAGGTCGTC
CAGCCTCAGGCAGCAGCTGAACCAACTCGCGAGGGGATCGAGCCCGGGGTGGGCGAAGAACTCCAGCATGAGATCCCCGC
GCTGGAGGATCATCCAGCCGGCGTCCCGGAAAACGATTCCGAAGCCCAACCTTTCATAGAAGGCGGCGGTGGGATCGAAA
TCTCGTGATGGCAGGTTGGGCGTCGCTTGGTCGGTCATACCCATGCCGGTACCGGATCCCTTGTACAGCTCGTCCATGCC
GAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAGGACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGG
ACTGGGTGCTCAGGTAGTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTCGGCG
AGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGATCTTGAAGTTCACCTTGATGCCGTTCTTCTGCTTGTCGGCCATGAT
ATAGACGTTGTGGCTGTTGTAGTTGTACTCCAGCTTGTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCA
GCTCGATGCGGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAAGAAG
ATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTGCTTCATGTGGTCGGGGTAGCGGCT
GAAGCACTGCACGCCGTAGGTCAGGGTGGTCACGAGGGTGGGCCAGGGCACGGGCAGCTTGCCGGTGGTGCAGATGAACT
TCAGGGTCAGCTTGCCGTAGGTGGCATCGCCCTCGCCCTCGCCGGACACGCTGAACTTGTGGCCGTTTACGTCGCCGTCC
AGCTCGACCAGGATGGGCACCACCCCGGTGAACAGCTCCTCGCCCTTGCTCACCATGCTAGCTTTGATTGATTTGACTGT
GTTATTTTGCGTGAGGTTATGAGTAGAAAATAATAATTGAGAAAGGAATATGACAAGAAATATGAAAATAAAGGGAACAA
ACCCAAATCTGATTGCAAGGAGAGTGAAAGAGCCTTGTTTATATATTTTTTTTTCCTATGTTCAACGAGGACAGCTAGGT
TTATGCAAAAATGTGCCATCACCATAAGCTGATTCAAATGAGCTAAAAAAAAAATAGTTAGAAAATAAGGTGGTGTTGAA
CGATAGCAAGTAGATCAAGACACCGTCTAACAGAAAAAGGGGCAGCGGACAATATTATGCAATTATGAAGAAAAGTACTC
AAAGGGTCGGAAAAATATTCAAACGATATTTGCATAAAATCCTCAATTGATTGATTATTCCATAGTAAAATACCGTAACA
ACACAAAATTGTTCTCAAATTCATAAATTATTCATTTTTTCCACGAGCCTCATCACACGAAAAGTCAGAAGAGCATACAT
AATCTTTTAAATGCATAGGTTATGCATTTTGCAAATGCCACCAGGCAACAAAAATATGCGTTTAGCGGGCGGAATCGGGA
AGGAAGCCGGAACCACCAAAAACTGGAAGCTACGTTTTTAAGGAAGGTATGGGTGCAGTGTGCTTATCTCAACCTTTGAT
TAGTTTATGGGCTAGCTTATGATACTTCCTCTTGCTGTTCCAGTTTACAAATGATTTAAACGAACTTCTACACTTTTACG
GTAGTATTTCTTGTTGGTGATGAGCTCAGATTCAATATGACTGCTTAATCAGTGAAAATTAATGGAAACAGCCAGACACA
CAGCCTTTGAAAAATGTTAAAAACGATCACATATATGTAGTCACGTGGTTAGTGCATAGAGTCAGGCGATGGTGGTTAGT
TCCCTAGCCAGAGCCATTCCCCTCTTGTTTCGAAATGCGATGACTGAATGGGGAAGAAGCTCTTAGTATTTCTGTAGTTT
TTTTTGCCGATTTCTATTGTTGCCTGCCCCGGACTTTCTTTTACCTTTTGTAGCTACAACTATTAATTATAATGCATAAT
AGATCTAGAAGCGTATTGTGATGAGCATCCTTGGAAATAAGAAAGGAAGTCACAGGTACAGTAAAAAAAGAGCCGTGACA
GGCACCTAATTTCAGTTTTGATTGAGGTATAATGAGCTCAGAAGACCAAGATGCTCTAAAAGTAAAGCAGAATGGTCTTT
CCAATCAGAATTCGTCACTTGTTGGTGCTTTAACTGCTGGTGGAAGATCTATGGTTTATCAGATGACTTCATTCTATATG
AGAACTCCACTAAAACTGTTTCGACCGGCCAGATTTGACTATACGCATTATATTCGAGTACTGTTGACTGGGAGTGATGA
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TACAAATAAGGATTCTAAGGTACGACGTTCAAAATATAAGTTTTGGAGTCCCAAATATACATACTACTTCGAAAATTCCT
CCATTGGAATAGTTACTAAGGCACTAAATAAGTATGGGTGGAAAGTTATTCCTGATAGAATATTGCCTCCTTTGGTGGCA
AATTCCCTTGCTGGGGTAGTTCTTTATACCACATACTTGACTACCCTGAATAATTTCCCAGTCAGATCAGTGGAGCCAGC
TTTTCAACACAATTTGTTTGACTACTTAAGGTAAGGGCGAATTCGCGGCCGCTAAATTCAATTCGCCCTATAGTGAGTCG
TATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGC
ACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTATACG
TACGGCAGTTTAAGGTTTACACCTATAAAAGAGAGAGCCGTTATCGTCTGTTTGTGGATGTACAGAGTGATATTATTGAC
ACGCCGGGGCGACGGATGGTGATCCCCCTGGCCAGTGCACGTCTGCTGTCAGATAAAGTCTCCCGTGAACTTTACCCGGT
GGTGCATATCGGGGATGAAAGCTGGCGCATGATGACCACCGATATGGCCAGTGTGCCGGTCTCCGTTATCGGGGAAGAAG
TGGCTGATCTCAGCCACCGCGAAAATGACATCAAAAACGCCATTAACCTGATGTTCTGGGGAATATAAATGTCAGGCATG
AGATTATCAAAAAGGATCTTCACCTAGATCCTTTTCACGTAGAAAGCCAGTCCGCAGAAACGGTGCTGACCCCGGATGAA
TGTCAGCTACTGGGCTATCTGGACAAGGGAAAACGCAAGCGCAAAGAGAAAGCAGGTAGCTTGCAGTGGGCTTACATGGC
GATAGCTAGACTGGGCGGTTTTATGGACAGCAAGCGAACCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGGAAG
CCCTGCAAAGTAAACTGGATGGCTTTCTTGCCGCCAAGGATCTGATGGCGCAGGGGATCAAGCTCTGATCAAGAGACAGG
ATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCT
ATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTT
GTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAAGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGT
TCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATC
TCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCG
GCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCA
GGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGAGCATGCCCGACGGCG
AGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGAC
TGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGA
ATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACG
AGTTCTTCTGAATTATTAACGCTTACAATTTCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGC
ATCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGC
TCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATAT
GAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCAT
AGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGC
GAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCA
ACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAA
CGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAG
TTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTC
TGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATAC
GGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGG
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ATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAG
CGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCA
TACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGACCAAAATCCCTTAACGTGAGTTTTCG
TTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTT
GCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTG
GCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCA
CCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGA
CTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAA
CGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGG
TATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCC
TGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCA
GCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCT
GTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAG
CGAGGAAGCGGAAG 
Figure 4 Plasmid TOPO/F7 sequences. 
Yellow: bleomycin gene, Cyan: GFP coding sequence, Green: ScPPDC1  
 
 
Results and Discussions 
Cold-tolerant yeast K. marxianus strain 
To characterize growth rates at various temperatures, K. marxianus NBRC1777 
and S. cerevisiae BY4741 were cultured at 5, 10, 20, 30, 37 and 45°C (Figure 5). The 
maximum specific growth rate (µmax) was higher for K. marxianus than for S. cerevisiae 
at all temperatures (Figure 5), indicating that the K. marxianus is a fast-growing strain. 
K. marxianus showed best growth at 37°C and was able to grow at 45°C. The difference 
in the µmax was also bigger at 10°C (0.079/0.044) compared to the difference at 20°C 
(0.23/0.20). Thus, in addition to the known thermotolerance of K. marxianus (Hong et al. 
2007), strain NBRC1777 exhibited fast and robust growth at a wide range of 
temperatures, a feature that will be appealing for a variety of industrial applications. 
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Figure 5 Cell growth of K. marxianus and S. cerevisiae at various temperatures. 
Cell growth was compared between K. marxianus NBRC1777 and S. cerevisiae 
BY4741 at 5, 10°C (a), at 20, 30°C (b), and at 37, 45°C (c). The maximum specific 
growth rate (µmax) was determined as the slope of the mid-log phase of natural 
logarithm (ln) (OD600). Timeframes for each µmax were as follows: at 5°C  from 33 h to 
168 h and 144 h to 216 h, at 10°C  from 19 h to 48 h and 42 h to 75 h, at 20°C  from 
16 h to 20 h and 16 h to 22 h, at 30°C  from 6 h to 8 h and from 6 h to 10 h, at 37°C  
from 2 h to 4 h and 5 h to 10 h, 45°C  from 3 h to 7 h and no growth for K. marxianus 
and S. cerevisiae, respectively. 
 
 
Isolation of KmSNR52 promoter for expression of sgRNA for CRISPR-Cas9 
To introduce the CRISPR system into K. marxianus, an efficient promoter for 
sgRNA expression was needed. As 5’-capped transcripts are not suitable for use as 
sgRNAs, PolII-driven promoters are not favoured. The SNR52 promoter has been used 
to express functional sgRNAs in S. cerevisiae (Dicarlo et al. 2013), so we obtained the 
K. marxianus SNR52 promoter (KmPSNR52) as follows. The K. marxianus SNR52 
transcript sequence was first identified using the BLASTN search program with the S. 
cerevisiae SNR52 transcript as a query. The region upstream of the putative KmSNR52 
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transcript was then aligned with the ScSNR52 promoter; a 531-bp fragment was thereby 
defined as the putative KmPSNR52 (Figure 3).  
We next constructed a vector for use as a shuttle vector by combining a K. marxianus 
autonomously replicating sequence (KmARS7) (Hoshida et al. 2014) with a centromere 
sequence (KmCEN-D) (Yarimizu et al. 2015) and demonstrated (data not shown) that 
this plasmid is retained as an episome in K. marxianus NBRC1777. A human-optimized 
Streptococcus pyogenes (Sp) cas9 (Dicarlo et al. 2013) under the control of the 
constitutive S. cerevisiae PDC1 promoter (ScPPDC1) was inserted into the shuttle vector, 
yielding a basal plasmid (Cas9_Base; Figure 1 and 6) capable of directing the 
expression of Cas9 in K. marxianus. 
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Figure 6 Construction of genome-editing plasmids. 
Constructed basal plasmids nCas9-CDA_Base and Cas9_Base are shown on the left. 
Target-containing sgRNA cassettes were constructed by overlap PCR using target 
sequence-containing primers (P_Km01-XXX, where XXX was a 3-digit number as 
shown in the figure) and then inserted into the basal plasmids at NotI and SpeI/NheI 
restriction enzyme sites. 
 
 
Inactivation of the NHEJ pathway by Target-AID point mutation of NHEJ 
proteins  
In S. cerevisiae, the NEJ1 and DNL4 genes encode core components of the proteins 
mediating NHEJ. By analogy to S. cerevisiae, disruption of the K. marxianus Nej1 and 
Dnl4 homologs are expected to yield more genetically tractable K. marxianus hosts with 
higher proportions of HR. Mutation of the K. marxianus Nej1 and Dnl4 genes identified 
by sequence similarity to the respective budding yeast genes was performed using 
targeted point mutagenesis by Target-AID in K. marxianus. A basal plasmid 
(nCas9-CDA_Base) was generated by constructing a variant of the Cas9_Base vector 
that encoded a nickase mutant (D10A) SpCas9 protein fused to the Petromyzon marinus 
(Pm)CDA1 cytidine deaminase (Nishida et al. 2016)
 
(Figure 2 and 6). Following a 
previous study in S. cerevisiae (Valencia et al. 2001), target sites in the Nej1 and Dnl4 
genes of K. marxianus NBRC1777 were selected so as to introduce stop codons by 
causing C-to-T mutagenesis at 16 to 19 bp upstream of the sequences encoding 
protospacer adjacent motif (PAM) sequences for the target sequences. K. marxianus 
NBRC1777 cells were transformed with plasmids containing each targeting sequence 
(nCas9-CDA_target Nej1 and nCas9-CDA_target Dnl4). G418-resistant colonies were 
selected; the Nej1 and Dnl4 genes of the transformants then were PCR amplified and 
subjected to sequence analysis to confirm the presence of the targeted lesions (Figure 7). 
Both plasmids introduced stop codons as expected, providing null alleles of Nej1 
(Nej1º) and Dnl4 (Dnl4º) with 1 of 8 (or 1 of 4) G418-resistant colonies contained the 
mutant allele, respectively. Thus, Target-AID was efficient enough to introduce targeted 
point mutation in K. marxianus. 
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Figure 7 Induction of mutations by Target-AID. 
The Nej1 and Dnl4 target sites were selected for the introduction of stop codons by 
Target-AID. Red boxes indicate the target sites and grey boxes indicate the PAM 
sequences. Lower-case nucleotide in red font indicates the mutated base. The sequences 
of the induced mutations are shown in alignment with the reference sequences, with 
each predicted amino acid sequence below the respective nucleic acid sequence. 
 
 
Conventional HR in NHEJ null mutants 
To investigate if these disruptions in genes with putative NHEJ activities increased 
the rate of HR in K. marxianus, cells of the Nej1º or Dnl4º mutants were transformed 
with DNA donor fragments with homology arms. Specifically, we employed a GFP bleo 
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cassette (i.e., encoding green fluorescent protein (GFP) fused to a protein providing a 
selectable marker for bleomycin/zeocin resistance) flanked by K. marxianus Ura3 
sequences. Two separate constructs were used, one providing extended homology 
(1000-bp arms at both ends) and the second providing shorter homology (arms of 122 
and 109 bp at the two ends). The fragments were expected to replace Ura3 with the 
GFP-bleo cassette if HR was facilitated by mutation of genes of the NHEJ pathway. 
The cells were transformed and selected for zeocin-resistance; the resulting 
transformants were then screened for 5-fluoroorotic acid (5-FOA) resistance, which 
would be conferred by Ura3 disruption. When using the construct providing homology 
arms of 1000 bp, 100% of the Zeo
R
 transformants of the Nej1º or Dnl4º strains (17/17 
and 13/13, respectively) were 5-FOA
R
; in comparison, only 26% (6/23) of the Zeo
R
 
transformants of the wild-type (WT) strain were 5-FOA
R
 (Figure 8). When using 
equimolar quantities of the construct providing shorter homology arms (122 bp/109 bp), 
123 Zeo
R
 transformants were obtained from the WT strain but no 5- FOA
R
 
transformants were obtained. The Nej1º or Dnl4º strains yielded one and two Zeo
R
 
transformants (respectively), of which no and one (respectively) were 5-FOA
R
 (i.e., 
disrupted at the targeted Ura3 locus) (Figure 8).  
Apparently, less number of transformants were obtained from the mutants of genes 
involved in NHEJ pathway, presumably because random integration was severely 
suppressed, rather than by increasing the HR frequency. This decrease in NHEJ 
facilitates reliable HR at the targeted (by homology) locus, although the obtained 
efficiency may not be sufficient to perform HR with short homology arms (i.e., of the 
length that can be added by PCR primers). 
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Figure 8 Effect of Nej1º and Dnl4º on homologous recombination. 
(a) Schematic of the transforming donor DNA fragment targeting the Ura3 locus. 
Dashed boxes indicate homologous regions. (b), (c) Homologous recombination rates 
(5-FOA resistant (inserted)/zeocin resistant (transformants)). Fragments were prepared 
either by PCR or by restriction digestion of plasmid (Cut). 
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HR with CRISPR-Cas9 
To boost the HR frequency, co-transformation with a construct encoding 
CRISPR-Cas9 was performed; the CRISPR system was expected to facilitate HR by 
providing cleavage of the targeted locus. A pair of target sites was selected at just inside 
of the homologous regions of Ura3. WT, Nej1º, and Dnl4º cells were transformed with 
the fragment with homology arms of 122 bp/109 bp (in combination with the Cas9 
construct) and transformants were selected using either zeocin, (Ura3-targeting 
fragment), G418 (CRISPR-Cas9 vector), or both. For all three strains, a larger number 
of antibiotic-resistant transformants were obtained when the transformation mixes 
included the CRISPR-Cas9 construct. Among the antibiotic-resistant transformants, 
41-79% of those derived from WT cells were 5-FOA
R
 (i.e., disrupted at Ura3), while 
95-100% of those derived from the Nej1º and Dnl4º strains were 5-FOA
R
 (Figure 9). 
These results indicated that target cleavage by Cas9 enhanced the frequency of HR 
sufficiently that even without selection by zeocin (i.e., without direct selection for the 
integration at Ura3), disruption of Ura3 was seen in virtually all transformants. 
73 
 
 
Figure 9 Homologous recombination facilitated by CRISPR-Cas9. 
(a) Schematic of the transforming donor DNA fragment targeting the Ura3 locus and 
CRISPR-Cas9 plasmid targeting two sites (indicated by red pie bolts) flanking the Ura3 
coding sequences (CDS). Dashed boxes indicate homologous regions. Bottom panel 
indicates (b) Homologous recombination rate (5-FOA resistant (inserted)/zeocin and/or 
G418 resistant (transformants) * 100). 
 
 
Markerless integration with 50-bp homology arms and CRISPR-Cas9 
Markerless integration was attempted by co-transformation using the combination 
of a donor DNA template containing a GFP expression cassette flanked by 50-bp 
homology arms along with a CRISPR-Cas9-encoding construct. Transformants were 
selected using G418 and then screened by both the 5-FOA test and PCR analysis. We 
observed successful integration (i.e., disruption of the Ura3 target locus in G418
R
 
74 
 
transformants) at rates of 28%, 84%, and 92% in the WT, Nej1º, and Dnl4º backgrounds, 
respectively (Figure 10). Taking advantage of the markerless integration, the 
GFP-encoding sequence was directly inserted into the coding sequence of the 
endogenous Sed1 gene so as to encode a GFP-Sed1 fusion protein preceded by the Sed1 
localization peptide. A single cleavage site for CRISPR-Cas9 within this target gene was 
designed in such a way that the site would not be retained after successful integration. 
Short (50-bp) homology arms flanking the target site were added to either end of the 
GFP-encoding sequence by PCR. Transformants were selected by G418 and then 
screened by PCR, revealing gene replacement at the Sed1 target locus at 38%, 100%, 
and 100% success rates in the WT, Nej1º, and Dnl4º backgrounds, respectively (Figure 
11). When viewed by fluorescence microscopy, cells harboring the targeted integration 
exhibited peripheral localization of GFP-Sed1, consistent with the localization 
previously reported for the equivalent construct in S. cerevisiae (Huh et al. 2003). Thus, 
this method can be applied for scar-less genome editing in K. marxianus. 
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Figure 10 Markerless integration with short homologous arms. 
(a) Schematic of the transforming donor DNA fragment targeting the Ura3 locus and 
the CRISPR-Cas9 plasmid targeting two sites (indicated by red pie bolts) flanking the 
Ura3 CDS. Dashed boxes indicate homologous regions. (b) Homologous recombination 
rate ((5-FOA resistant*PCR check)/ transformants (G418 resistant)*100). 
 
 
 
Figure 11 Direct fusion of GFP-coding sequence into a chromosomal locus.  
(a) Schematic showing integration of the GFP-coding fragment into the Sed1 CDS. The 
CRISPR-Cas9 plasmid targeted (indicated by red pie bolts) the end of the signal 
peptide-coding region of Sed1. Dashed boxes indicate homologous regions. Left arm is 
homologous to the end of to the signal peptide-coding sequence (bp 8 to 57 with respect 
to the start of the Sed1 coding sequence). Right arm is homologous to Sed1 sequence 
(bp 58 to 107 with respect to the start of the Sed1 coding sequence) with substitution at 
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bp 84 (G to A; indicated by lower-case letter in red font) to eliminate a PAM. (b) The 
successful integration rate was calculated as PCR check*100. (c) Representative 
microscopic image of positive transformants (Nej1º/GFP_Sed1) under bright-field (left) 
and fluorescent (right) illumination. Insets show 3-fold magnified images. 
 
 
Assembly and integration of multiple fragments without markers 
In vivo assembly and integration of multiple fragments was performed using three DNA 
fragments, each containing 50 bp overlap with the adjacent fragments or target sites, 
such that the entire construct was designed to replace Ura3 (Figure 12). Compared to 
single PCR product donor constructs, a smaller number of transformants was obtained 
by G418 selection when using the multiple-fragment DNA as the donor. Nonetheless, 
the WT, Nej1º, and Dnl4º strains showed integration efficiencies of 18% (2/11), 100% 
(3/3), and 100% (4/4), respectively. This assembly and integration method is expected 
to allow combinatorial integration of gene cassettes using (for example) combinations 
of various promoters and coding regions.  
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Figure 12 In vivo assembly and integration of three DNA fragments with 50 bp 
overlaps. 
(a) Schematic of the three transforming donor DNA fragments replacing the Ura3 locus 
along with the CRISPR-Cas9 plasmid targeting two sites (indicated by red pie bolts) 
flanking the Ura3 CDS. Dashed boxes indicate homologous regions. Bottom panel 
shows (b) Homologous recombination rate (5-FOA resistant * PCR check)/ 
transformants (G418 resistant)*100. 
 
 
In summary, targeted point mutagenesis (by Target-AID) and markerless 
CRISPR-mediated integration were demonstrated in K. marxianus using a fast-growing 
strain that was shown to exhibit both thermo- and cold-tolerance. Mutation of Nej1 or 
Dnl4, loci encoding homologs of NHEJ proteins, enhanced the proportion of HR events. 
These genome-engineering tools are expected to greatly facilitate industrial use of K. 
marxianus, a prototype for the class of underexploited non-conventional yeasts. 
 
  
78 
 
References 
Abdel-Banat B. M. A., Nonklang S, Hoshida H, Akada R., 2009. Random and targeted 
gene integrations through the control of non-homologous end joining in the yeast 
Kluyveromyces marxianus. Yeast. 27, 19–39. 
 
Dicarlo JE, Norville JE, Mali P, Rios X, Aach J, Church GM., 2013. Genome 
engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids 
Res. 41, 4336–4343. 
 
Dudášová Z, Dudáš A, Chovanec M., 2004. Non-homologous end-joining factors of 
Saccharomyces cerevisiae. FEMS Microbiol. Rev. 28, 581–601. 
 
Feldmann H, Driller L, Meier B, Mages G, Kellermannu J, Winnacker EL., 1996. HDF2, 
the second subunit of the Ku homologue from Saccharomyces cerevisiae. J. Biol. Chem. 
271, 27765–9.  
 
Gietz D, St Jean A, Woods R a, Schiestl RH., 1992. Improved method for high 
efficiency transformation of intact yeast cells. Nucleic Acids Res. 20, 1425.  
 
Hong J, Wang Y, Kumagai H, Tamaki H., 2007.  Construction of thermotolerant yeast 
expressing thermostable cellulase genes. J. Biotechnol. 130, 114–123.  
 
Hoshida H, Murakami N, Suzuki A, Tamura R, Asakawa J., 2014. Non-homologous 
end joining-mediated functional marker selection for DNA cloning in the yeast 
Kluyveromyces marxianus. 31, 29–46.  
 
Huh W-K, Falvo J V, Gerke LC, Carroll AS, Howson RW, Weissman JS, et al., 2003. 
Global analysis of protein localization in budding yeast. Nature. 425, 686–691.  
  
79 
 
Inokuma K, Ishii J, Hara KY, Mochizuki M, Hasunuma T, Kondo A., 2015. Complete 
Genome Sequence of Kluyveromyces marxianus NBRC1777, a Nonconventional 
Thermotolerant Yeast. Genome Announc. 3, e00389-15.  
 
Jakočiūnas T, Jensen MK, Keasling JD., 2016 CRISPR/Cas9 advances engineering of 
microbial cell factories. Metab. Eng. 34, 44–59.  
 
Jeong H, Lee DH, Kim SH, Kim HJ, Lee K, Song JY, et al., 2012. Genome sequence of 
the thermotolerant yeast Kluyveromyces marxianus var. marxianus KCTC 17555. 
Eukaryot. Cell. 11, 1584–1585.  
 
Moore JK, Haber JE., 1996. Cell cycle and genetic requirements of two pathways of 
nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae. 
Mol. Cell. Biol. 16, 2164–2173.  
 
Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, et al., 2016. 
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune 
systems. Science. 353, aaf8729-1-aaf8729-8. 
 
Nonklang S, Abdel-Banat BM a, Cha-aim K, Moonjai N, Hoshida H, Limtong S, et al., 
2008. High-temperature ethanol fermentation and transformation with linear DNA in 
the thermotolerant yeast Kluyveromyces marxianus DMKU3-1042. Appl. Environ. 
Microbiol. 74, 7514–7521.  
 
Da Silva N a, Srikrishnan S., 2012.  Introduction and expression of genes for 
metabolic engineering applications in Saccharomyces cerevisiae. FEMS Yeast Res. 12, 
197–214.  
  
80 
 
Suzuki T, Hoshino T, Matsushika A., 2014. Draft Genome Sequence of Kluyveromyces 
marxianus Strain DMB1, Isolated from Sugarcane Bagasse Hydrolysate. Genome 
Announc. 24, e00733-14.  
 
Valencia M, Bentele M, Vaze MB, Herrmann G, Kraus E, Lee SE, et al., 2001. NEJ1 
controls non-homologous end joining in Saccharomyces cerevisiae. Nature. 414, 666–
669.  
 
Wagner JM, Alper HS., 2016. Synthetic biology and molecular genetics in 
non-conventional yeasts: Current tools and future advances. Fungal Genet. Biol. 
Elsevier Inc. 89, 126–136.  
 
Yarimizu T, Nakamura M, Hoshida H, Akada R., 2015. Screening of accurate clones for 
gene synthesis in yeast. J. Biosci. Bioeng. 119, 251–259.  
 
 
81 
 
Chapter 3 
Genetic and physiological basis for antibody production  
by Kluyveromyces marxianus 
 
Introduction 
Production of biopharmaceuticals requires the difficult choice of a host cell 
capable of generating the desired product in an active and safe form, devoid of 
unwanted modification or contamination. Additionally, some biopharmaceuticals such 
as antibodies have proven difficult to express at high levels. Chinese hamster ovary 
(CHO) cells and yeasts are the major hosts that have been engineered to produce 
biopharmaceutical products, including antibodies (Maccani et al. 2014). As mammalian 
cells, CHO cells produce mammalian-derived proteins in an active form, bearing 
appropriate modifications such as glycosylation. However, the development of stable 
cell lines takes very long times (6 to 12 months), and the cost of cell culture is very high 
(Lai et al. 2013). Yeast cells such as Pichia pastoris may provide much faster and 
cheaper ways of production (Çelik and Çalık 2012); while this yeast can be engineered 
to serve as a suitable hosts, highly complex proteins such as antibodies can be difficult 
to express efficiently in this system (Nielsen 2013).  
Due to difficulties in expression, secretion, and post-translational modification, 
antibodies intended for clinical use remain a challenge to produce in a cost-effective 
manner (Buckholz and Gleeson 1991; Huang et al. 2014). Single-chain Fv antibody 
(scFv) is one of the most useful forms of antibody, consisting of a single polypeptide in 
which the variable regions of the heavy (VH) and light (VL) chain domains are fused by 
a short, flexible linker; the resulting product has a molecular weight of approximately 
30 kDa (Damasceno et al. 2004). Unlike large immunoglobulins (IgGs), scFv proteins 
have demonstrated rapid tumor penetration (Yokota et al. 1992). A prototypical scFv is 
the anti-chicken (anti-hen) egg white lysozyme antibody (HyHEL-10), which has been 
used for the precise analysis of antigen-antibody interactions (Tsumoto et al. 1997).  
The non-conventional yeast Kluyveromyces marxianus can grow on various sugars 
(glucose, xylose, fructose, sucrose, inulin, etc.) (Fonseca et al. 2008; Lane and 
Morrissey 2010; Lertwattanasakul et al. 2011). K. marxianus is known to secrete 
proteins such as inulinase into the culture medium at high levels (Rouwenhorst et al. 
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1990; Hu et al. 2012). Engineering of K. marxianus for protein production has been 
reported for both endogenous and heterologous enzymes (Raimondi et al. 2013; Hong et 
al. 2007). However, there are to date (to our knowledge) no reports on secretory 
antibody production in K. marxianus.  
The K. marxianus NBRC1777 strain recently has been shown to exhibit rapid 
growth and adaptability to a wide range of temperatures (from 5°C to 45°C). 
Additionally, comprehensive genome engineering tools recently have been introduced 
for use in this strain, including a Clustered Regularly Interspaced Short Palindromic 
Repeat (CRISPR) -associated protein (CRISPR-Cas9) system and deaminase-mediated 
base editing Target-AID (Nambu-Nishida et al. 2017). NBRC1777 is expected to be of 
use for various bio-production applications, including the secretion of high-value 
proteins.  
In the present study, we introduced K. marxianus NBRC1777 as a novel host for 
scFv production. Several parameters were examined, including the type of secretion 
signal and growth conditions such as temperature, carbon source, and medium. Genetic 
backgrounds that affect protein production or secretion also were studied.  
 
 
Materials and Methods 
Strains and culture conditions 
The K. marxianus and S. cerevisiae strains used in this study are listed in Table 1. 
Escherichia coli strain DH5α (Toyobo, Osaka, Japan) and yeast cells were grown as 
described previously (Nambu-Nishida et al. 2017). 
 
INU1 gene disruption 
The inu1 gene-disrupted strain and homologous recombination strains were 
generated using the CRISPR-Cas9 system. The CRISPR-Cas9 vector plasmid 
(Cas9_Base) of K. marxianus, target sgRNA cassette construction, and methods were as 
described previously (Nambu-Nishida et al. 2017). The inu1 deletion strain was 
generated by using a Cas9 plasmid (E02-026) containing gRNA-1 and gRNA-2 target 
sequences (Table 2 and Figure 1a).
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Table 1 Plasmids and strains used in this study 
Plasmids and Strains Genotype Reference 
Plasmids 
  
E02-012 KmPMDH1_KmINU1ss_scFv_TTDH3, KmARS7, KmCEN D, kanMX, ori, and AmpR This study 
E02-014 KmPACO1_KmINU1ss_scFv_TTDH3, KmARS7, KmCEN D, kanMX, ori, and AmpR This study 
E02-020 KmPMDH1_Scα-MFss_scFv_TTDH3, KmARS7, KmCEN D, kanMX, ori, and AmpR This study 
E02-022 KmPACO1_Scα-MFss_scFv_TTDH3, KmARS7, KmCEN D, kanMX, ori, and AmpR This study 
Cas9_Base ScPPDC1_Cas9_TTDH3, KmARS7, KmCEN D, kanMX, ori, and AmpR (Nambu-Nishida et al. 2017)  
E02-025 
KmPSNR52_target_gRNA-1_sgRNA_Tsup4 cassette and 
KmPSNR52_target_gRNA-3_sgRNA_Tsup4 cassette in Cas9_Base 
This study 
E02-026 
KmPSNR52_target_gRNA-1_sgRNA_Tsup4 cassette and 
KmPSNR52_target_gRNA-2_sgRNA_Tsup4 cassette in Cas9_Base 
This study 
   
Strains 
  
1 (NBRC1777) Wild-type (WT) 
NITE  
Biological Resource Center, Japan 
Nej1° Nej1 disrupted by C to T point mutation at posision 13 (Nambu-Nishida et al. 2017)  
Dnl4° Dnl4 disrupted by G to A point mutation at posision 44 (Nambu-Nishida et al. 2017)  
2 (Km02-026) WT/E02-012 This study 
3 (Km02-032) WT/E02-014 This study 
4 (Km02-050) WT/E02-020 This study 
5 (Km02-056) WT/E02-022 This study 
Δinu1 (Km02-063) Nej1°/Δinu1 This study 
84 
 
6 (Km02-064) Nej1°/inu1::PINU1_scFv This study 
7 (Km02-065) Dnl4°/inu1::PINU1_scFv This study 
8 (Km02-066) Nej1°/inu1::/E02-020 This study 
   
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ATCC (Brachmann et al. 1998))  
 
Table 2 Target sequence used in this study 
Name Sequence (5' → 3') 
gRNA-1 TATAAAATGTCGCTGTGACC 
gRNA-2 CAACTACAACCGGATACCTG 
gRNA-3 ATGGAAGCAAGAGGGAGTAT 
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Figure 1 Design of INU1 disruption and replacement 
(a) A schematic of the INU1 locus and its deletion is shown. Reverse complement 
sequences of target (red) and PAM (shadowed) are shown on the reference sequence. 
The lower part of the panel shows an alignment of the sequence from the deletion strain 
with the sequence of the wild-type locus.  
(b) A schematic of the INU1 replacement by a fragment encoding scFv is shown. The 
mutated PAM sequence and its reverse complement sequence are highlighted in yellow. 
Mutated bases are indicated as small red letters. The scFv-encoding fragment also 
encodes the INU1 secretion signal peptide (blue box) and a 6-histidine tag (red box) 
in-frame with the expressed ORF. 
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Replacement of INU1 by integration of a scFv-encoding sequence  
A fragment encoding HyHEL-10 scFv (scFv hereafter) (Acchione et al. 2012) was 
codon optimized for expression in K. marxianus (Figure 2). The homologous 
recombination strain was generated by transforming the recipient strain by the lithium 
acetate method (Gietz et al. 1992), using 10 µg of Cas9 plasmid (E02-025) containing 
gRNA-1 and gRNA-3 target sequences (Table 2 and Figure 1b) and 5 µg of the 
sequence-optimized fragment encoding scFv (Figure 3). The transformed cells were 
plated on YPD containing the appropriate selection reagent (100 μg/ml G418). 
 
Verification of genome-edited cells 
Transformants generated using the CRISPR-Cas9 system were screened by colony 
PCR using the primer pair P_Km01-010 + P_Km01-010-011. DNA sequence of the 
resulting amplicon was confirmed by sequencing using a 3130xL Genetic Analyzer 
(Applied Biosystems, CA, USA). The transformant cells were grown without selection 
reagents to isolate a clone that dropped the Cas9 plasmid. 
 
Construction of scFv expression plasmids 
The constructed plasmids are listed in Table 1. Plasmid E02-014, which includes 
KmARS7, KmCEN-D, the scFv-encoding fragment, KmPACO1, and the kanMX 
selectable marker (which provides G418 resistance) is shown as an example (Figure 4). 
Constructs incorporated either the PMDH1 (KmPMDH1) (Figure 5) or PACO1 
(KmPACO1) (Figure 6) promoters from K. marxianus. Constructs also incorporated 
sequences encoding either the secretory signal sequence from inulinase (KmINUss) 
from K. marxianus (Bergkamp et al. 1993) or that from α-MF (Scα-MFss) from S. 
cerevisiae (Melorose et al. 1986). Fragments carrying the desired promoter fragment 
and encoding the desired signal sequence were inserted into the NheI or SbfI/BamHI 
sites of the E02-014 plasmid using In-fusion cloning (Takara Bio, Shiga, Japan). The 
resulting scFv expression plasmids were transformed into K. marxianus NBRC1777 or 
the inu1 deletion strain by the transformation and selection methods noted above.   
87 
 
DIQLQESGPSLVKPSQTLSLTCSVTGDSITSDYWSWIRKFPGNRLEYMGYVSYSGSTYYNPSLKSRISITRDTSKNQYYL
DLNSVTTEDTATYYCANWDGDYWGQGTLVTVSAGGGGSGGGGSGGGGSDIVLTQSPATLSVTPGNSVSLSCRASQSIGNN
LHWYQQKSHESPRLLIKYASQSISGIPSRFSGSGSGTDFTLSINSVETEDFGMYFCQQSNSWPYTFGGGTKLEYKHHHHH
H* 
Figure 2 Amino acid sequence of scFv 
Yellow: VH, Light green: VL, Red: 6-His-tag 
 
 
TTTTTTTTTGTTAGATATGAAGTTAGCATACTCCCTCTTGCTTCCATTaGCAGGAGTCAGTGCTTCAGTGATCAATTACA
AGAGAGACATCCAATTGCAAGAATCTGGTCCATCCTTGGTTAAGCCATCCCAAACCTTGTCTTTGACTTGTTCCGTCACC
GGTGACTCTATCACTTCCGATTACTGGTCTTGGATTAGAAAGTTCCCTGGTAACAGATTGGAATACATGGGTTACGTTTC
TTACTCCGGTTCTACCTACTACAACCCATCTTTGAAGTCCAGAATCTCTATTACCAGAGACACTTCCAAGAACCAATACT
ACTTGGACTTGAACTCTGTCACCACTGAAGATACCGCTACTTACTACTGTGCCAACTGGGACGGTGACTACTGGGGTCAA
GGTACCTTGGTTACTGTCTCCGCTGGTGGTGGTGGTTCTGGTGGTGGTGGTTCTGGTGGTGGTGGTAGTGACATCGTTTT
GACTCAATCCCCAGCTACTTTGTCTGTTACCCCTGGTAACTCCGTCTCTTTGTCCTGTAGAGCCTCTCAATCCATCGGTA
ACAACTTGCACTGGTACCAACAAAAGTCCCATGAATCTCCAAGATTGTTGATTAAGTACGCCTCTCAATCCATCTCTGGT
ATTCCATCTAGATTCTCCGGTTCTGGTTCCGGTACCGACTTCACTTTGTCCATTAACTCTGTTGAAACCGAAGATTTCGG
TATGTACTTCTGTCAACAATCTAACTCCTGGCCATACACTTTCGGTGGTGGTACCAAGTTGGAATACAAGCACCATCACC
ATCACCATTAATAATCTGATCTGCTCTGCTTACTTTACTAACGACAAAAAAAAATCCAAAAAAAAAAAAAAATCCACTAT
TATTAAAACAAATCAGTCCTTCTCTTCTTACGATATGATATGATTAAATGATACTATGAAATCATCTTCTTCTTAACTTT
CTTAAATCTTACACGTCACTTACTCTATATACCCGTTTAGCTTTGCaTGGTCACAGCGACATTTTATATAAGTGTACGTA
TTTTCTTTTTTTTT 
Figure 3 Sequence of inserted scFv fragment 
Pink: Homologous regions, Yellow: VH, Light green: VL, Red: 6-His-tag 
 
 
GTGAATTTACTTTAAATCTTGCATttaaataaattttctttttatagctttatgacttagtttcaatttatatactattt
taatgacattttcgattcattgattgaaagctttgtgttttttcttgatgcgctattgcattgttcttgtctttttcgcc
acatgtaatatctgtagtagatacctgatacattgtggatgctgagtgaaattttagttaataatggaggcgctcttaat
aattttggggatattggcttttttttttaaagtttacaaatgaattttttccgccaggatGCGGCCGCgaattcagggat
gatcttgagaagttcttagagtcttacgagggaacagaagatttggaaccagccaaagctgctatagcggaagcagatat
tttgctaagtaaatgattaaataattaaatatgtggaaatacattaatctttttatatttttgcagttcgttgtcgctat
aatttatagtcatctcgttagttcaaacaagacttcttgaagtgaaaaccaactttcagtcttcaaactaaaaatgaaaa
tcagtggaagaaggtaaacgacttcatgttatatatgaattgaatagtaatggaaataaccaaaaacagctcaacagaaa
acaaacaaaatacgttaagacctgaactcctagcagaaccataactgccaaatatttattatctgtggagatcttatatt
ctaaaaccaaaaaaaatataacttaaaagttaaaaagaagatgttctaactgaggttcgaactcaggacctttgccgtgt
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gaaggcaacgtgatagccactacactattagaactaccttatgggaaaaagaaaaatagagtacaactagaatggtaaga
tctgtgaccttttctaaacacttaattccatatagacagttcccacccaccataaggtcacaattataatgtctttagaa
gaccactgtcgttcatcatcttcctaagccctctctctaaagcggcatatttccgtaatttgttcttctttgcacaggca
cgtgagatgactccgattattcccacatgcatatttagcCTCTCTAGGGGCTCGAGCTATAGCAAGTTCAAGGAAAGaaa
acTATTATGATCTGGTCACGTGTATAAAATTTATTAATTTTAAAACTATATAATTTATTATTTTTTTATTTTAAAGTTTA
AAGTAATTTTAATAGTATTCTATATTTTAAATAAACATACTTTAAAATTTTATTTAATAATTTATTATTTTTAAATACAA
TGTTTTTATTTAAAACAAAATTATAAGTTAAAAAGTTGTTCCGAAAGTAAAATATATTTTATAGgacgtcGACATGGAGG
CCcagaataccctccttgacagtcttgacgtgcgcagctcaggggcatgatgtgactgtcgcccgtacatttagcccata
catccccatgtataatcatttgcatccatacattttgatggccgcacggcgcgaagcaaaaattacggctcctcgctgca
gacctgcgagcagggaaacgctcccctcacagacgcgttgaattgtccccacgccgcgcccctgtagagaaatataaaag
gttaggatttgccactgaggttcttctttcatatacttccttttaaaatcttgctaggatacagttctcacatcacatcc
gaacataaacaaccatgggtaaggaaaagactcacgtttcgaggccgcgattaaattccaacatggatgctgatttatat
gggtataaatgggctcgcgataatgtcgggcaatcaggtgcgacaatctatcgattgtatgggaagcccgatgcgccaga
gttgtttctgaaacatggcaaaggtagcgttgccaatgatgttacagatgagatggtcagactaaactggctgacggaat
ttatgcctcttccgaccatcaagcattttatccgtactcctgatgatgcatggttactcaccactgcgatccccggcaaa
acagcattccaggtattagaagaatatcctgattcaggtgaaaatattgttgatgcgctggcagtgttcctgcgccggtt
gcattcgattcctgtttgtaattgtccttttaacagcgatcgcgtatttcgtctcgctcaggcgcaatcacgaatgaata
acggtttggttgatgcgagtgattttgatgacgagcgtaatggctggcctgttgaacaagtctggaaagaaatgcataag
cttttgccattctcaccggattcagtcgtcactcatggtgatttctcacttgataaccttatttttgacgaggggaaatt
aataggttgtattgatgttggacgagtcggaatcgcagaccgataccaggatcttgccatcctatggaactgcctcggtg
agttttctccttcattacagaaacggctttttcaaaaatatggtattgataatcctgatatgaataaattgcagtttcat
ttgatgctcgatgagtttttctaatcagtactgacaataaaaagattcttgttttcaagaacttgtcatttgtatagttt
ttttatattgtagttgttctattttaatcaaatgttagcgtgatttatattttttttcgcctcgacatcatctgcccaga
tgcgaagttaagtgcgcagaaagtaatatcatgcgtcaatcgtatgtGAATGCTGGTCGCTATACTGGAGCTCCAGCTTT
TGTTCCCtttagtgagggttaattgcgcgcttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgct
cacaattccacacaacataggagccggaagcataaagtgtaaagcctggggtgcctaatgagtgaggtaactcacattaa
ttgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagctgcattaatgaatcggccaacgcgcgggg
agaggcggtttgcgtattgggcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagc
ggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaag
gccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagcatcac
aaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccct
cgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctc
atagctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcag
cccgaccgctgcgccttatccggtaactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagc
cactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtggtggcctaactacggctaca
ctagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttggtagctcttgatccggc
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aaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaaga
tcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaa
aaaggatcttcacctagatccttttaaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtct
gacagttaccaatgcttaatcagtgaggcacctatctcagcgatctgtctatttcgttcatccatagttgcctgactccc
cgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccgcgagacccacgctcac
cggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctcc
atccagtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgc
tacaggcatcgtggtgtcacgctcgtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacat
gatcccccatgttgtgcaaaaaagcggttagctccttcggtcctccgatcgttgtcagaagtaagttggccgcagtgtta
tcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgcttttctgtgactggtgagta
ctcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgc
cacatagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttg
agatccagttcgatgtaacccactcgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagc
aaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcgacacggaaatgttgaatactcatactcttcctttttc
aatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtatttagaaaaataaacaaata
ggggttccGCGGCGCGCCGCTAGCGCTCCGATCCTCGGAGGCAGGGTCACCCCAGCCACCTGTTACCCAACCGAAATAGG
AATAAAAAAATCCCCAAAAGAACAAACAAACTTTTCCCCCTTTGCCGAACCTCGGAAAAGACCACTTTTCAATGACAACC
CTTACTCGGCCCCGGTTTCCGGGTACGCTTCCGAATACCCTGCACATGCCCCCTCTGCATGGATGTATGGAGAGGCCCTT
CCTGCTTGCCCCATTGCAAAAAAAATATCACAAACATACCCCTACACTGCAGCCGTTTCTTAGTGCAGTCCAATCACGTC
GCGTATTTGTTCGTGATCACATAATCACAACTACAGCTCTTTCTAAGCATTGAAACCATGTCCTCTTGCATACGCTCCTA
CGGCACTAACCGCGCTGTTCTCTGTCTGGCCCTTGCGTCCCAACCATGCCATGCTGCTTCCTAGACACACACACGCACTC
AGCTCACCAGAGAACAAACAAAACTCCATTTATTCAGATCGCTCCCGTCACTTCAGAAGAGAAAATTTTTTTTCCCATTC
TTCTACTTGTGCTTCTGCTGCGCTGCCTTCGTGTTTCGAGTTGTTTTTAGGTTGGGCGTTAGCCAGTATAATGAAATTGA
GTGATCAATCGGCGGCGAATCGATCAAATTGATGACTTTTTTTTTTTTTTTTTTTTTGGGAGGTAAATTACGTTGAAAGC
TTGTGCTTATTGTAGTTGTATCTCTATACAAACGTAAATTTTAATATGTACAGTAGTAATTGTAGTAATAATAATAATAA
TAATAATAACACAATTAATTGTATATATAAGGGATTTCCGATTGGCTCCGTCTATATATTTTTTTTGTTCTTTGGGCAAG
TATAAAAAGTTCGAATAGTTGTTGCAGTTTTTTGGGAGTCCGTATTTTTTAGTTTATTATTAGTTTATAGGCTATTAGTT
TGTTATAATTGTATACAATTCGTTTTAATCGAACAAGAACAACAAACCATATCATCTGTTGATAGCTAGCTCCGGACCTG
caggGATATGAAGTTAGCATACTCCCTCTTGCTTCCATTGGCAGGAGTCAGTGCTTCAGTGATCAATTACAAGAGAGGAT
CCGACATCCAATTGCAAGAATCTGGTCCATCCTTGGTTAAGCCATCCCAAACCTTGTCTTTGACTTGTTCCGTCACCGGT
GACTCTATCACTTCCGATTACTGGTCTTGGATTAGAAAGTTCCCTGGTAACAGATTGGAATACATGGGTTACGTTTCTTA
CTCCGGTTCTACCTACTACAACCCATCTTTGAAGTCCAGAATCTCTATTACCAGAGACACTTCCAAGAACCAATACTACT
TGGACTTGAACTCTGTCACCACTGAAGATACCGCTACTTACTACTGTGCCAACTGGGACGGTGACTACTGGGGTCAAGGT
ACCTTGGTTACTGTCTCCGCTGGTGGTGGTGGTTCTGGTGGTGGTGGTTCTGGTGGTGGTGGTAGTGACATCGTTTTGAC
TCAATCCCCAGCTACTTTGTCTGTTACCCCTGGTAACTCCGTCTCTTTGTCCTGTAGAGCCTCTCAATCCATCGGTAACA
ACTTGCACTGGTACCAACAAAAGTCCCATGAATCTCCAAGATTGTTGATTAAGTACGCCTCTCAATCCATCTCTGGTATT
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CCATCTAGATTCTCCGGTTCTGGTTCCGGTACCGACTTCACTTTGTCCATTAACTCTGTTGAAACCGAAGATTTCGGTAT
GTACTTCTGTCAACAATCTAACTCCTGGCCATACACTTTCGGTGGTGGTACCAAGTTGGAATACAAGCACCATCACCATC
ACCATTAACCCGGGactagt 
Figure 4 Sequence of E02-014 plasmid 
Gray: ScTTDH3, Cyan: KmARS7, Green: KmCEN-D, Yellow: kanMX, Light green: 
KmPACO1, Red: KmINU1ss, Pink: scFv 
 
 
GCATGCACCATGTTACCCGGGGGGCATCCATGTCTCTCCCTTCCTCTTCCTCTTTTTTTACTAATTTCCCTGTTGTCTTC
CGTTTTTTTCTTTTTTTCCCCTATCGCCAATGCATGACCAAAGTCCTTTTTTTTTTTCCCCATGACACAGCCCGTTGGAA
CACGCTGAAAACACGCTGAAGAAAAACAAGGGAAACACTGGAACAGTGAAACACCCGCACGAAAATGTTCGGAGTCGGCT
CCGCGTGGTCCCAATTAATAAACAACGTAGCAGCTAGCCAGCTTTAAACTGACTTAGTCCTACGGTTTTGCTGCGTGGGG
GAACCGAGGGAGGGAATCCTCTGGAAGCCGGACCTTGCCCTTTTGACTAGGGTACTACTCTGGGCAGGGTACTTACTAAA
CTGGGCCCAGACAGACAGAGGCCCAGACAGAGGCCCCAAAGAGAAGCCGCCAGGTTCCCTGCCTAGGCCTTCCTCTGGTT
GCCCCCCAGAGTACCCTCCGGAACGAAACGAAACGAAAACGCACATCGTGATGCGCGCTATTATAATTGCGTCTTGCGAA
TTCCATACGCCATGCGCTTAGTTAGCACATGAAATCCTGCCAATATTGACAATCCAACTTCCCAATTCCATTCCCAATTC
CATTCCTACCTAATTCCAGTTCCCATTCATGACCACCGCCGACTCGCCCACAGTTGGCCCACAATTGGCCCATATAATAT
CAGGATATCAGAAAAATAGTTACATATATACAAACAAATTGAAAAATATATATATTATATATTATGGATATTAATATTAT
ATATATATATATGTATATATATCATGACATAAAGCTTTGATTGATAATAATACCTCTACTTCTTGGTATGATAATGTGAT
CTCTTGCTATCTTATTCCTTTATCTAACACCCCCCCCAAGTACATACATATACTACTACACA 
Figure 5 Sequence of KmPMDH1 
 
GCTCCGATCCTCGGAGGCAGGGTCACCCCAGCCACCTGTTACCCAACCGAAATAGGAATAAAAAAATCCCCAAAAGAACA
AACAAACTTTTCCCCCTTTGCCGAACCTCGGAAAAGACCACTTTTCAATGACAACCCTTACTCGGCCCCGGTTTCCGGGT
ACGCTTCCGAATACCCTGCACATGCCCCCTCTGCATGGATGTATGGAGAGGCCCTTCCTGCTTGCCCCATTGCAAAAAAA
ATATCACAAACATACCCCTACACTGCAGCCGTTTCTTAGTGCAGTCCAATCACGTCGCGTATTTGTTCGTGATCACATAA
TCACAACTACAGCTCTTTCTAAGCATTGAAACCATGTCCTCTTGCATACGCTCCTACGGCACTAACCGCGCTGTTCTCTG
TCTGGCCCTTGCGTCCCAACCATGCCATGCTGCTTCCTAGACACACACACGCACTCAGCTCACCAGAGAACAAACAAAAC
TCCATTTATTCAGATCGCTCCCGTCACTTCAGAAGAGAAAATTTTTTTTCCCATTCTTCTACTTGTGCTTCTGCTGCGCT
GCCTTCGTGTTTCGAGTTGTTTTTAGGTTGGGCGTTAGCCAGTATAATGAAATTGAGTGATCAATCGGCGGCGAATCGAT
CAAATTGATGACTTTTTTTTTTTTTTTTTTTTTGGGAGGTAAATTACGTTGAAAGCTTGTGCTTATTGTAGTTGTATCTC
TATACAAACGTAAATTTTAATATGTACAGTAGTAATTGTAGTAATAATAATAATAATAATAATAACACAATTAATTGTAT
ATATAAGGGATTTCCGATTGGCTCCGTCTATATATTTTTTTTGTTCTTTGGGCAAGTATAAAAAGTTCGAATAGTTGTTG
CAGTTTTTTGGGAGTCCGTATTTTTTAGTTTATTATTAGTTTATAGGCTATTAGTTTGTTATAATTGTATACAATTCGTT
TTAATCGAACAAGAACAACAAACCATATCATCTGTTGATA 
Figure 6 Sequence of KmPACO1 
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SDS-PAGE and immunoblot analysis 
To analyze protein production, soluble proteins in the spent culture medium were 
separated on a SDS-polyacrylamide 12.5% gel (ATTO, Tokyo, Japan) and stained with 
Bio-Safe Coomassie Stain (Bio-Rad, Hercules, CA). MagicMark™ XP Western Protein 
Standard (Thermo Fisher Scientific Inc., MA, USA) was included as the molecular 
weight standard. For western blotting, proteins were transferred to a polyvinylidene 
fluoride (PVDF) membrane (EDM Millipore, Billerica, MA, USA) by electroblotting. 
The membrane then was blocked by incubation for 1 h at room temperature with 
Blocking One (Nakarai tesque, Kyoto, Japan), followed by washing with TBST (0.1 M 
Tris-HCl, 0.15 M NaCl, 0.05% Tween 20). The membrane then was incubated for 1 h 
with the primary antibody, rabbit anti-6-His Antibody Affinity Purified (Bethyl 
Laboratories, TX, USA) diluted 1:5000, followed by washing with TBST and 
incubation for 1 h with the secondary antibody, Peroxidase AffiniPure Goat Anti-Rabbit 
IgG (H+L) (Jackson ImmunoResearch Laboratories, PA, USA) diluted 1:10000. Protein 
bands were detected by ImmunoStar Zeta (Wako, Osaka, Japan). 
 
Enzyme-linked immunosorbent assay (ELISA) 
Strains were cultured in YPD or YPX (10 g/L yeast extract, 20 g/L peptone, and 20 
g/L xylose) supplemented with 100 mM sodium phosphate buffer, pH 6.0, and selective 
agent for plasmid-bearing strains in the absence or presence of 200 mM MgSO4 
selective medium. Culturing was performed in 96-well deep-well plates at 20°C or 30°C 
with shaking at 1,200 rpm. 
For ELISA, a MaxiSorp plate (Thermo Fisher Scientific Inc.) was coated by 
distribution of 50 μL per well of lysozyme formulated at 1 μM in 1x phosphate-buffered 
saline (PBS (10x stock), Nacalai Tesque, Kyoto, Japan) followed by overnight 
incubation at 4°C. The plate then was blocked at 25°C for 1 h with the blocking solution 
(ImmunoBlock, DS Pharma Biomedical, Japan) diluted 1:5 in water. The plate was 
washed three times with PBST (1x PBS supplemented with 0.1% Tween-20 and 2% 
blocking solution). Supernatants (spent medium) from cultures were diluted five-fold in 
PBST containing 2% ImmunoBlock and distributed at 50 μL/well. All ELISAs included 
a blank consisting of 70 μL PBST containing 2% ImmunoBlock. Following incubation  
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at 25°C for 1 h, the plate was washed as above, and antibody (Anti-His-tag 
mAb-HRP-DirecT, MLB, Nagoya, Japan), diluted 1:8000 in PBST, was distributed at 
50 μL/well. The plate was incubated at 25°C for 1 h and then washed with PBST as 
above. Color was developed using TMB 1-Component Microwell Peroxidase Substrate 
Sure Blue and TMB Stop Solution (KLP Inc, Milford, USA) according to 
manufacturer’s instructions. Activity was then measured as absorbance at 450 nm using 
a SpectraMax Paradigm Multi-Mode Microplate Reader (Molecular Devices Japan, 
Tokyo, Japan). Relative activity of scFv was obtained by subtracting the value of blank. 
 
 
Results 
Disruption of INU1 gene by CRISPR-Cas9 system 
Wild-type K. marxianus predominantly secretes inulinase (Rouwenhorst et al. 
1988; Hu et al. 2012). To facilitate the purification of the heterologous protein and 
re-direct cellular resources for protein production, we deleted the corresponding INU1 
gene. A CRISPR-Cas9 vector for K. marxianus (Nambu-Nishida et al. 2017) expressing 
a pair of guide RNAs (gRNA-1 and gRNA-2) flanking the INU1 coding region was 
constructed and used to transform the parent strain; transformants were then screened 
for the inu1 mutation (Figure 1a). For integration of the scFv-encoding sequence at the 
INU1 locus, we employed strains deficient in the non-homologous end-joining (NHEJ) 
repair pathway (in this instance, harboring nej1° or dnl4° null mutations) 
(Nambu-Nishida et al. 2017) to facilitate homology-directed integration. Another vector 
expressing a pair of guide RNAs (gRNA-1 and gRNA-3) flanking the INU1 coding 
region (Figure 1b) was designed and transformed in combination with an scFv-encoding 
fragment. The scFv-encoding fragment was flanked with arms (85 bp and 240 bp for the 
upstream and downstream sequences, respectively) with homology to the INU1 ORF. 
PAM sequences of the targets in the arms were mutated to prevent re-cutting after 
successful integration. Vector-carrying transformant cells were PCR-amplified and 
subjected to agarose gel electrophoresis (Figure 7). Sequence analysis of the deletion 
transformant confirmed that the chromosomal INU1 locus harbored a 2565-bp deletion 
between the gRNA-2 and gRNA-1 targeting sites, yielding Δinu1 (Km02-063) strain 
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(Figure 1a). Sequence analysis of the transformants from the gene-replacement 
experiment confirmed that the INU1 ORF had been replaced by sequences encoding 
scFv; two of the resulting constructs were designated strains No. 6 (Km02-064) and 
No.7 (Km02-065) (Figure 1b and 8b). Note that these two strains include nej1° or dnl4°, 
respectively. Next, the strains were assessed for inulinase secretion. 
SDS-PAGE analysis of spent culture medium recovered from the wild-type strain 
revealed a single major band at approximately 90 kDa (Figure 8c), consistent with the 
expected size of inulinase (Hong et al. 2014). Notably, this band was absent in spent 
medium from cultures of the inu1 constructs, as expected (Figure 8c). 
 
Figure 7 INU1 deletion and replacement analyzed by agarose gel electrophoresis 
Sequences from the transformed cells were PCR-amplified and analyzed by agarose gel 
electrophoresis. A pair of primers (P_Km01-010 + P_Km01-011) flanking the INU1 
locus were used to amplify intervening sequences. The resulting amplicons from the 
wild-type strain (lane 1), inu1-deleted strain Δinu1 (Km02-063) (lane 2), or scFv 
integration strains No. 6 (Km02-064) (lane 3) and No. 7 (Km02-065) (lane 4) matched 
the expected fragment sizes of 3057 bp, 492 bp, 2184 bp, and 2184 bp, respectively. 
DNA ladder markers (1 Kb and 100 bp) are provided as size standards (lanes M1 and 
M2, respectively).  
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Figure 8 INU1 deletion analyzed by SDS-PAGE and secretion of scFv analyzed by 
immunoblotting 
(a) Schematic of the general construction of scFv-expression plasmid. kanMX: G418 
resistance gene, KmCEN-D: centromere sequence of K. marxianus, KmARS7: 
autonomous replication sequence of K. marxianus. 
(b) Combinations of promoters and signal peptides tested.  
(c) Stains were cultivated for 48 h in YPD with or without G418, and SDS-PAGE was 
used to analyze the spent culture medium from strains No. 1 (wild-type) (lane 1), No. 6 
(Km02-064) (lane 2), No. 7 (Km02-065) (lane 3), and No. 8 (Km02-066) (lane 4). Sizes 
of the molecular weight marker (lane M) are indicated on the left.  
(d) Immunoblot of spent culture medium from strains cultivated for 72 h in YPD with or 
without G418. Lane numbers correspond to those in panel (b).  
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Figure 4 Immunoreactivity of secreted scFv analyzed by ELISA 
Strains were cultured in YPD or YPX in the absence or presence of MgSO4 at 20°C (a) 
or 30°C (b). Spent culture medium was harvested at 72 h and subjected to ELISA using 
lysozyme as an antigen for scFv. Values are presented as mean ±SEM from three 
independent experiments. 
 
 
Expression and secretion of scFv antibody 
For the expression of scFv, various expression cassettes containing combinations 
of promoters (PMDH1, PACO1 ) and secretion signal (KmINUss, Scα-MFss) -sequences 
were introduced, either via plasmid or by genomic integration (Figure 8a and b). Protein 
expression and secretion was assessed by immunoblotting of spent growth medium 
(Figure 8d). Secretion of scFv was confirmed as the presence of an approximately 30 
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kDa protein (Damasceno et al. 2004) in the spent growth medium from each of the 
transformed strains tested (Figure 8d). These results indicated that these promoters and 
secretion signals functioned in a modular fashion. 
 
Activity of scFv antibody and improved production by magnesium sulfate 
supplementation 
We next sought to identify growth conditions, including the use of various media, 
that would yield enhanced expression and secretion of the intact scFv protein. Cells 
were grown, with shaking in 96-well deep-well plates, at temperatures of 20°C or 30°C 
in YPD or YPX medium in the presence or absence of various supplements and 
subjected to ELISA to detect the presence of intact secreted scFv. In this context, ELISA 
measured the immunoreactivity of scFv. MgSO4 was found to have substantial impact 
on the antibody production in K. marxianus (Figure 9a and b). At 20°C, all strains 
exhibited increased activity when grown in YPD plus MgSO4 (Figure 9a). At 30°C, 
more than 10-fold increased activity was observed for strains No. 6 (Km02-064) and No. 
7 (Km02-065), both of which harbor constructs introduced by genomic integration, 
when grown in xylose medium containing MgSO4 (Figure 8b and 9b). Deletion of INU1 
yielded about 4.4-fold increase in scFv activity in xylose medium containing MgSO4, 
when comparing strain No. 4 (Km02-050) (harboring a plasmid-borne construct) and 
strain No. 8 (Km02-066) (INU1 disruptant harboring a plasmid-borne construction) 
(Figure 8b and 9b). 
 
 
Discussions 
In this study, we demonstrated that K. marxianus NBRC1777 can be engineered to 
express and secrete a single-chain antibody. We showed that secretion of scFv could be 
changed substantially by use of various genetic constructs and by modification of the 
growth conditions. 
The recently introduced CRISPR-Cas9 and Target-AID genome editing systems 
(Nambu-Nishida et al. 2017) permit genetic manipulation of organisms that had 
previously been underexploited because of a lack of genetic tools. In the present work, a 
sequence encoding scFv was integrated into the INU1 locus without an associated 
selection marker. This construct allowed robust expression of the integrated gene 
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without a need for continued use of selection reagents. The strains (Nos. 6 and 7) 
carrying the integrated construct showed dramatic increases in scFv immunoreactivity, 
which is attributed to either increased expression and secretion or improved quality of 
the antibody, or both. (compared to strains expressing scFv via plasmid-borne 
constructs) when grown in YPX plus MgSO4 at 30°C (Figure 9b). Further work will be 
needed to determine whether increased expression requires genomic integration in 
general or at the INU1 locus specifically. It is formally possible that episomal plasmids 
are not well retained during outgrowth, especially if protein expression creates stress for 
the host cell.  
In our hands, YPX medium induced increased expression from the INU1 promoter 
but not from the other tested promoters (Figure 9a and b). As the INU1 product 
inulinase metabolizes inuline to fructose (Rouwenhorst et al. 1988), INU1 is 
downregulated in the presence of glucose, the preferred sugar (Jain et al. 2012). 
Moreover, INU1 gene expression is known to be up-regulated when fructose replaces 
glucose as a sugar source (Schabort et al. 2016), and the INU1 promoter has consensus 
binding sequences for MIG1, a known repressor of transcription in the presence of 
glucose (Bergkamp et al. 1993). As inulinase is the predominant protein secreted by K. 
marxianus (Rouwenhorst et al. 1990; Hu et al. 2012), deletion of the encoding locus is 
expected to permit re-direction of resources for expression and secretion of 
heterologous proteins. The present work showed that deletion of INU1 had a positive 
but limited impact on scFv production in strain No. 8 (Km02-066). This limited effect 
may have reflected the use of the KmPMDH1 promoter and the Scα-MFss signal peptide. 
In Kluyveromyces lactis, the Trichoderma reesei CBH1 secretion signal was more 
efficient than that of the native α-mating factor for directing the secretion of a reporter, 
Enhanced Green Fluorescent Protein (EGFP) (Madhavan and Sukumaran 2014). Use of 
the endogenous INU1 signal peptide in K. marxianus may provide more efficient 
production by directing the heterologous protein into the secretion pathway typically 
used by inulinase. 
In K. marxianus, lysine aminopeptidase activity is higher at 30°C than at 20°C 
(Ramírez-Zavala et al. 2004). It would be valuable to assess the in vivo role of various 
processing enzymes, for instance by suppressing the activity of endogenous proteases 
by using either protease inhibitors or genetic manipulations. 
A positive effect of MgSO4 was observed (to some extent) in all strains and 
conditions, indicating that MgSO4 generally facilitates the production/secretion of intact 
scFv in K marxianus (Figure 9a and b). Considering the concentration of MgSO4 in the 
defined media that typically ranges up to 10 mM or so, 200 mM of MgSO4 apparently 
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exceeded the nutritional demands of the cell. The addition of divalent metal ions, 
including Mg
+2
, has been reported to enhance bacterial ell growth and enzyme 
production (Venkateswarulu et al. 2017; Shahbazmohammadi and Omidinia 2017). The 
effect of divalent metal ions may result from changes to membrane permeability 
(Venkateswarulu et al. 2017). In the present study, we observed drastic increases in 
antibody secretion in the presence of 200 mM MgSO4, a concentration that is ten times 
higher than that tested in bacteria. While fungal protein secretion pathways differ from 
those of bacteria, high concentrations of MgSO4 may also affect membrane organization 
in eukaryotes, facilitating protein secretion and/or stimulating expression of genes that 
contribute to enhanced protein production and secretion. Although MgSO4 is expected 
to be involved in a wide range of fungal cellular and biochemical processes, the 
mechanism of this MgSO4-mediated enhancement of scFv production remains unclear. 
Nonetheless, our study demonstrated that there is potential for further enhancing fungal 
protein production by both genetic and physiological manipulations. 
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General Conclusion 
 
In this thesis, I aimed at providing basic information and technology for yeast 
genetic engineering and cost-effective culture for the sake of industrial production from 
biomass.  
 
In chapter 1, gene expression profile of S. cerevisiae producing ethanol was studied 
as a model biomass-based production. Detailed time-course changes in the activity of 
major 30 promoters were quantitatively analyzed in various conditions including xylose 
utilization, which simulates biomass-derived resource. A few promoters were found to 
be active in microaerobic xylose fermentation, while most others showed poor activity. 
These will provide useful information for optimization of gene expression to improve 
growth and production from biomass in yeast. 
 
In chapter 2, K. marxianus was selected to explore its industrial potential as it 
exhibited good proliferative property and thermotolerance. Comprehensive genetic 
engineering tools were provided by applying cutting edge genome editing technology 
for K. marxianus. Efficient gene knock-out and knock-in was achieved without use of 
selection marker. This approach will facilitate engineering of underexploited yeasts and 
other microbes for industrial applications. 
 
Antibody production as high value-added product was performed using K. 
marxianus in chapter 3. Genetic engineering, promoter selection and optimization of 
media condition were together proved to be effective in the improvement of production. 
   
The research on S. cerevisiae as eukaryotic model provides highly integrated and 
comprehensive understanding with the aid of highly accumulated previous researches. 
Genome editing technology now allows easy genetic manipulation of minor yeasts that 
have useful characteristics. This thesis demonstrated an approach in which studying 
model organism as reference and establishing new host strain with practical advantages  
coordinately facilitate industrial application for bio-based material production.  
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